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INTRODUCTION 
                  Siddha medicine is one of the most antiquated traditional medical 
systems with codified references from age old literature. It surfaced more than 
2500 years ago. Siddha system of medicine is based upon panchaboothas (5 
elements) mukkutram (tridosha) theory & sapthathadu theory. Panchaboothms 
& mukkutram are present in the 96 thathuvas which are basic principles of the 
medicine. 
                 The medical system that blossomed at lemuria with the colour of 
tamil literature is called as siddha. Siddha system of medicine is one of the most 
old system of medicine curing  major diseases in a proper way without any 
harm and major toxic effects. This system of medicine cures diseases on the 
basis of dhosa’s. The siddhar’s who are the eminent founders of this ancient 
system had written various types of medicines to cure the variation in the 
dhosas. 
                  When the normal equilibrium of 3 humors (vadha, pittha, kaba) is 
disturbed, disease occurs.. The factors which affect this equilibrium are 
environment, climatic conditions, diet, physical activities & stress. Under 
normal conditions the ratio between these three humors (vadha, pittha, kaba) is 
1:1/2:1/4 respectively. According to the siddha medicine system diet & life style 
plays a major role. This concept of siddha medicine is termed as pathya & 
apathya. 
The drug used by the siddhars could be classified into 3 groups: 
• Thavaram (herbal product) 
• Thathu      (inorganic substance) 
• Jeevam       (animal products) 
 
 
According to their mode of application the siddha medicine could be 
categorized into two classes. 
• Internal medicine – used through oral route & further classified into 32 
categories based on their form , methods of preparation. 
• External medicine – it includes certain forms of drugs & also certain 
application like nasal , eye ,ear drops & also certain procedures like leech 
application, purgative therapy, emetic, fasting, steam, physical therapies, 
solar therapies, bloodletting, yoga,thokkanam,ottradam etc. 
                          Osteo arthritis also known as degenerative arthritis or 
degenerative joint disease or osteoarthrosis is a group of mechanical 
abnormalities involving degradation of joints including articular cartilage & 
subchondral bone. Symptoms may include joint pain, tenderness, stiffness, 
locking & sometimes an effusion. A variety of causes – hereditary, 
developmental, metabolic & mechanical  may initiate processes leading to loss 
of cartilage. When bone surfaces become less well protected by cartilage, bone 
may be exposed & damaged. As a result of decreased movement secondary to 
pain, regional muscles may atrophy & ligaments may become more lax. 
          Treatment generally involves a combination of exercise, lifestyle 
modification & analgesics. Azhal keel vayu is the most common problem of 
elder person. 
                     For this reason I have chosen Azhal keel vayu.My trial drug is 
KARUNGOZHI CHOORANAM as internal medicine and VIDAMUTTI 
THYLAM as external medicine. 
  
 
 
AIM AND OBJECTIVES 
 AIM:  
 The aim of this dissertation is to bring out the most treatable drug without 
side effects from siddha system of medicine for “Azhal keel vaayu”. 
OBJECTIVES: 
Primary objectives: 
 To evaluate the clinical efficacy of Karungozhi Chooranam as internal 
medicine and Vidamutti Thylam as external medicine for the disease “Azhal 
keel vaayu”. 
Secondary objectives: 
• To study the efficacy of sirappu maruthuvam techniques like  varmam, 
aasanas and external therapies like thokkanam(massage) and 
ottradam(fomentation) which are useful in treating “Azal keel vaayu” 
along with internal and external medicine. 
• To collect the evidences found in siddha literature for “Azhal keel 
vaayu”. 
• To confirm the diagnosis in siddha system with the help of modern 
parameters. 
• To compare the clinical features given under Azhal keel vaayu with the 
features of osteoarthritis. 
• To know the chemical and pharmacological analysis of the selected drug. 
  
 
 
SIDDHA ASPECT 
“jkpo; kz;lyike;Je; jhtpa Qhdk; 
ckpo;tJ Nghy Tyfe; jphpthh; 
mtpO kdKnkk; khjp awpTe; 
jkpo;kz; lyike;Je; jj;Jt khNk”  
- jpUke;jpuk;  
 
gd;dPuhapuk; Mz;Lfl;F Kd; Njhd;wp rpj;jhe;j NguwptpaYf;Fj; 
Jizahf Njhd;wp rpj;j kUj;Jtk; mg;Nguwptpiy tiue;j rpj;jh;fNs 
tioue;J> vk;kf;fSk; mjidf; fw;wwpUe;J ePLop thor; nra;jnud;gJ 
kpifahfh.  
“tPu kUe;njd;Wk; tpz;Nzhh; kUe;njd;Wk;  
ehhp kUe;njd;W ee;jp aUs; nra;jhd; 
Mjp kUe;njd; wwpth GfyplQ; 
Nrhjp kUe;jpJ nrhy;ynthz; zhjNj” 
jkpo;ehl;by; Njhd;wpa nkhop> Nguwptpay;> kUj;Jtk; Mfpait 
rptdhy; nra;ag;gl;lit vdf; $wp mij rptd; ee;jpf;Ff; fw;gpj;jhd; 
vdTk;> ee;jp jpU%yh;f;Fk;> jpU%yh; kw;w rpj;jh;f;Fk; fw;gpj;jhnud xU 
rhuhh; $Wth;. ,t;thW ngwg;gl;l rpj;j kUj;Jthpd; ,ay;ghf mfj;jpah; 
gpd;tUkhW $Wfpwhh;. 
“cj;jk Fzq;f Ss;Nshd; 
cah;ngUq; fPh;j;jp As;Nshd;. 
Gj;jpah yha;e;J nrhy;Nthd;. 
nghUs;fisaha ty;Nyhd; 
 
 
rj;jpa thh;j;ij As;Nshd; 
jUk rpe;jidNa As;Nshd; 
Fj;jpu thh;j;ij Ngrhf; 
Fzd; ghpfhhp ahNk” 
-mfj;jpah;. 
kUj;JtDf;F %d;W fz;fs; vd;gij fPo;f;fz;l mbahy; mwpayhk;.  
'%d;W fz;Zs;NshhpUtuhk; 
md;d tHah nudpy; 
Md;w NyhfkPd;  wspg;gtd; 
Mfpa tuDk; 
Njhd;w kf;flk; Jahpidg;  
Nghf;fpL Nthdhk; 
vd;w khkUj; JtDNk 
vd tpak;GtNu  
kUj;jtdpd; 3 fz;fs; vit vd;gij 
“kUe;J Rj;jp Fz epfz;L fz;fs; %d;whk;”  
1. Purification of medicine  
2. Diagnosis of disease and character of medicine  
3. The different nomenclature of medicine  
“mz;lj;jpy; cs;sNj gpz;lk; 
gpz;lj;jpy; cs;sNj mz;lk;" 
    -rl;lKdp Qhdk;  
 
 
In this sentence says that “Man is considered as the microcosm; Universe is 
considered as the macrocosm”. It shows that Human body is the replication of 
universe. 
 Universe made up of 5 elements i.e earth air, water, ether and fire. 
Human body also made up of this panchaboothas.  
“Ik;g+jk; gj;jhf;fp” 
This line says that one of the fire elements combined with the other four 
elements in different proportions to form the human body. These are the basic 
reason for “Urirthathu” This Uyirthathu divided into their thodas known as 
vatham, Pittham and kabam.  Any deviation (or) derangement occur in this there 
Uyrithathu may produce “Disease”. 
KEEL VAYU. 
Other Names 
According to siddha maruthuvam text book keel vayu mentioned as santhu vali, 
Mutthu vali, Meha soolai, Mudakku vayu and ama vatham. 
• Vitiated vatha produces disease in keel (Joints) called as keel vayu. 
• Pain in muttu  (Joint) called as muttuvalli.  
• Inability to use (mudakku) joints called as muddakku vayu, 
• Improper digestion of food followed by increased kabam produces vadha 
disease called as “Amavatham”  
• This disease followed by meha noi called as “mehasoolai”. 
According to Agathiyar Gunavagadam keelavayu mentioned as: 
“jhdhd fPy;thj Nuhfk; Ngiu  
rhw;WfpNwd; ePawpa tpgukhf  
 
 
khdhd tha;T Nuhfk; thjNuhfk;  
kfj;jhd Klf;Ftha;T Klf;F thjk; 
Njdhd re;jpf rpNyl;Lk Nuhfk; 
njspthd iffhypy; gpbg;G Nuhfk; 
Cdhd urthjk; R+iyf;fl;L  
cj;jkNd re;jpthjk; thj R+iyahNk” 
     -mfj;jpah; Fzthflk;. 
IYAL (DEFINITION) 
 Keel vayu in one of vatha disease which is characterised by swelling, 
pain, stiffness of the joints, difficulty to flex and extend the joint. This disease 
associated with fever when increased vatha is along with Kabam. 
  “tspA ikAe; jd;dpiy nfl;L 
  typAld; tPf;fr; RuKk; fha;e;J  
  Kl;Lf NlhWk; KLf;fpNa nehe;J  
  Kl;Lf ld;dpd; ePUk; Rue;J 
  jhq;nfhzh typAld; nehe;jpL kk;Nk” 
  -rghgjp ifNaL. 
AZHAZ KEEL VAYU: 
 When it is Vatha vitiated, diet and habits which stimulates Pittha it will 
produce “Azhal Keel Vayu”.  
 
 
 
NOI VARUM VAZHI: (AETIOLOGY) 
1. Causes of ‘Keel Vayu” from Sabapathy Kaiyedu is as follows: 
“ tspjU fha; fpoq;F 
tiutpyh japyy; Nfhio 
Kspjaph; Nghd;kpFf;F 
Kiwapyh Tz;b Nfhly; 
FspHjU tspapw; Nwfq; 
Fdpg;Gw Tyty; ngz;bh; 
fspj;jU Kaf;fk; ngw;Nwhh; 
fbnray; fUtpahkhy;”. 
Diet and health which gives rise to Vatha dhosa (i.e) excessive intake of 
potato like roots and banana, excessive intake of cold substances like curd, 
exposure to cold, staying in hill station which increase Kabam causes this 
disease. Further this disease is followed by mega noi and may be hereditary. 
2. According to “Yugi Muni” Aetiology is defined as follows: 
“ vd;dNt thjk; jhndz;gjhFk; 
,fj;jpNj kdpjh;fSf; nfa;AkhW 
gpd;dNt nghd;jiia NrhuQ;nra;J 
nghpNahh;fs; gpuhkziu J~zpj;Jk; 
td;dNjtw; nrhj;jpr; NrhuQ; nra;J 
khjhgpjhFUit kwe;j Ngh;f;Fk; 
fd;dNt Ntjj;ij epe;ij nra;jhy; 
fhaj;jpw; fye;jpLNk thje;jhNd” 
 
 
 
“jhnddw; frg;NghL Jth;g;Giwg;G 
rhjfkha; neQ;Rf;fpDQ; rikj;j tz;zk; 
Mndd;w thwpdJ nghrpj;jyhYk; 
Mfhaj; NjwyJ Fbj;jyhYk; 
ghndd;w gfYhwf;f kpuh tpopg;G 
gl;bdpNa kftpWj;jy; ghunka;jy; 
Njndd;w nkhopahh;Nkw; rpe;ijahjy; 
rPf;fpukha; thjkJ nrdpf;Fe;jhNd” 
- A+fpitj;jpa rpe;jhkzp 
Intake of foods which are rich in taste like bitter, astringent and chilly, 
intake of old cooked foods, drinking of rain water, day time sleeping, 
awakening at night, starvation, excessive weight lifting and sexual 
perversion may produce Vadha disease. 
3. In "Theraiyar Vagadam” the cause of Vadha disease is mentioned as 
follows. 
 “nta;apypy; elf;ifahYk; kpfj;jz;zPh; Fbf;ifahYk; 
  nra;apio kfspdiur; Nrh;e;jDgtpf;ifahYk; 
  igaNd cz;ikahYk; ghfw;fha; jpz;ifahYk; 
 ijaNy thjNuhfk; rdpf;F nkd;wwpe;J nfhs;Ns”. 
 - Njiuah; thflk;. 
Walking on hot weather, excessive intake of water, over sexual 
indulgence, intake of bitter gourd may produce Vadha disease. 
4. Another concept from “Pararaja Sekaram” denotes the causative factor of 
Vadha disease as follows. 
   “fhzNt kpfTz;lhYk; fUJgl;bdp tpl;lhYk; 
 khdid ahh;fz; Nkhfkwf;fpD kpFe;jpl;lhYk; 
 Mzt kyq;flk;ik aq;qNd tplhjyhYk; 
 
 
 thDjd; jley; yhNsthjq; Nfhgpf;Fk; fhNz” 
 
Over eating, undue starving, sexual perversion, Anavamalam will produce 
vadha disease. 
“ghhpdpw; gag;gl;lhYk; gyUld; Nfhgpj;jhYk; 
fhundf; fUfpNahbf; fOkuj; Juj;jpdhYk; 
Vh;ngW jdJ neQ;rpd; kpfj;Jf;f kile;jpl;lhYk;  
ghhpa fw;wpdhYk; glhpDk; thjq;fhZk;” 
Fear, anxiety, tension, stress will lead to Vadha disease. 
5. In Agathiyar Kanma Varalaru – 300, Vadha disease is to be considered as one 
among the Kanma noi,  
 “E}nyd;w thjk; te;j tifjh NdJ 
 Ez;ikaha; fd;kj;jpd; tifiaf; NfS 
 fhypNy Njhd;wpa fLg;Ng NjJ 
 iffhypy; Klf;fpaJ tPf;fNkJ 
 NfhypNy gLf;fpd;w tpUl;rkhd 
 Foe;ij kue;jid ntl;ly; Nky;Njhy;rPty; 
 ehspNy rPtnre;Jfhy; Kwpj;jy; 
 ey;y nfhk;Gjio Kwpj;jy; eypj;jy;jhNd" 
       - mfj;jpah; fd;k tuyhW – 300 
 
 
 
6. Vadha disease followed by Meha noi and Ama Vatham 
7. Food Variations: 
 Diet plays a vital role in preserving the human body. The food is formed 
on the basis of 6 tastes. 
 “GspJth; tpQ;Rq;fwp ahw;G+hp f;Fk; thjk;” 
       - fz;Zrhkpak;. 
Sour and astringent taste causes an increase in Vadham. 
8. Environmental change: 
 The environmental factors (Thinai) may also pave the way for the 
development of disease. 
Neithal: People of this land suffer from Vadha diseases. Further it leads to 
increased body mass, enlargement of liver and flatulence. 
Palai: The people of this land suffer from disease of 3 thoshas.  
9. Seasonal Variations: 
Due to seasonal variations changes in thridhosa occur which leads to disease. 
 “thjth;j;jd fhyNkNjh ntd;dpy; 
 kUTfpd;w Mdp fw;fl khjk; 
 Mjidg; grpNahL fhh;j;jpif jd;dpy; 
 mlUNk kw;w khjq;fs; jd;dpy; 
 NghfNt rkpf;fpd;w fhykhFk;" 
Vadha disease most common in the months from Aani to Karthikai. 
 
 
 
In Muthuvenil Kalam (Aani and Aadi) Vadham gets aggrevated. 
In Kaar Kalam (Avani and Puratasi) – Vadham in increased state. 
 
NOI ENN (Classification) 
Keelvayu is Classified into 10 types 
 Valikeel Vayu 
 Azhalkeel Vayu 
 Iya Keel Vayu 
 Vali azhal Keel Vayu 
 Vali iya keel Vayu 
 Azhal vali keel Vayu 
 Azhal iya keel Vayu 
 Iya vali Keel Vayu 
 Iya azhal Keel Vayu 
 Mukkutra keel Vayu. 
SIDDHA ASPECT 
“PATHOLOGY OF KEEL VAYU”. 
“tspA ikAe; jd;dpiy nfl;L” – rghgjpifNaL. 
I. VITATED DHOSHA OF VADHA: 
“gpzpapDw; gj;jpiag; NgRtd; gpzpKjy; 
thj gpj; jq;fg kd; ke;jphp je;jphp 
tPjkh Alyuz; nka;k;Gu tuR nra; 
Kiw nrAkhjyhd; ……..” 
  - Njiuah; fhg;gpak;. 
 
 
According to Siddha aspect, Vatham is the initiator of all the activities of our 
body. So Theran said Vatham as "Arasan" in the above lines. 
"Azhal Keel Vayu" is described in Sarabentthier Kaiyedu Nool. It is the most 
common Vadha disease. Incresed Vatha may produce pain, stiffness, deformity 
which is dealed on below siddha books. 
1. “Fwpnadf; iffhy; Fsr;R tpyhr; re;J 
gwpnad nehe;Jlw; gr;irg; Gz;zhFk;. 
  -jpU%yh;. 
2. “nrhy;yNt thjkJ kPwpw; whdhy; 
Nrhh;tile;J thAtpdhy; Njfnkq;Fk; 
nky;yNy iffhy;f srjp Az;lhk; 
nka;Klq;Fk; epkpunthz;zh jpkpUz;lhFk;” 
     - mfj;jpah; 
3. “fhNzg;gh thj kPwpy; 
fhy;iffs; nghUj;jp NehFk;” 
    - fhtpaj;jpd; ehb. 
4. “Nktpa thjQ; nra;Aq; 
Fzq;jid tpUk;gpf; NfS 
jhtpa tapW ke;jQ; 
re;Jfhy; nghUe;J Nehthk;” 
    - ,uj;jpdr; RUf;fk; ehb. 
 
Increased Vadha produces 6 characteristic features. 
  “thjq; fLik twl;rpAld; neha;ik 
  rPjQ; rydk; rpjwZT – VjKl 
  dpf;Fzj;Njh Lw;Nw apaf;fe; jUkstpw; 
  wf;f ghpfhue; jh”. 
      - fz;Zrhkpak;. 
 
 
1. fbdk; 
2. twl;rp 
3. ,NyR 
4. Fsph;r;rp 
5. mirjy; 
6. mZj;Jtk;. 
 
We could take two characteristic features from above song. 
1. twl;rp – Dryness.  
The fluid around the joint is dried. It is compared to modern pathology, 
which says that some protective factors which protect the cartilage from 
aging process. Normal cartilage has 2 main components. 
1. Extracellular Matrix 
2. Aggrecan contains glucosaminoglycans chain 
of chondroitin sulphate and keratin sulphate that is capable of 
retaining water. 
 During aging, quantitative and qualitative changes in aggrecan reduce 
the capacity of the molecules to retain water. thus aged cartilage 
contains less water. 
  2. mirjy; - Movements. 
 In Azha keel Vayu, increased vadha produces restricted movements. This 
is mentioned in sabapathy kaiyedu as follows. 
  “ Kl;Lf NlhWk; KLf;fpNa nehe;J” 
 
 
 
 
VITIATED DHOSHA OF KABAM: 
  “ tspA ikAe; jd;dpiy nfl;L…..” 
       - rghgjp ifNaL. 
 When vadha is increased along with vitiated kabam dhosham produces 
pain, stiffness, swelling and restricted movement. 
Nature of Iyam: 
  “jplkPA nkd;gpizg;Gj; jpz;ikAw;w ahg;Gk; 
   mlNyh; tOtOg;Gk; Mf;iff; fplh;f;F 
  ntUthg; nghWikAk; NkNyhd fhg;ghk; 
  ngUikj;jh ikankdg; NgR" 
       - kUj;Jt ghujk; 
In this song nature of Iyam was described. They are: 
 1. Steadiness (Nilaitthal) 
2. Lubrication (Neippu) 
 3. Structure of joints 
 4. Patience (Poraiyudaimai) 
One of the 5 types of Iyam santhigam act as a lubricator for mobilization of 
joints. 
  “ %l;Lf ld;dpd; ePUk; Rue;J” 
 
 
 
 
This line denotes increased Iyam leads to swelling of joints 
 
 
   
 
  
Increased Vadha               Increased Pittham               Increased Iyam 
 
Pain       Fever    Swelling 
Stiffness  
Restricted Movement  
 Diet and habits which increase the Pittham along with vitiated Vadha 
dhosam may produce this disease.  
CLINICAL FEATURES : 
  “gpj;jf;fPy; tha;T jd;dhw; 
   gpwq;FfPd; %l;L tPq;fpr; 
   rpj;jh;nra; kUe;J tj;JQ; 
   rPh;glhj; jd;ikj; jhfpj; 
   jj;JW fha;r;ry; fz;L 
   rhyNt jidjhd; je;Nj 
   nkj;jW rpfpr;ir jd;dhy; 
   nkd;Nky; ePq;F kg;gh” 
Dietary Variation 
& 
Habits 
 
 
      - rghgjp ifNaL. 
• Swelling of the joint 
• Fever 
• Restricted movement 
• Swelling of the joints will increased day by day. Increased Pittham act as 
synovid theid between the joint space which dries it. It make sound like 
“Kaluk, Kaluk” when the movement of the joint. Sometimes it may cause 
inable to move the joints.  
MUKKUTRA VERUBADUGAL 
In Azhal keel vayu the following vayus are affected. 
Vatham Physiological function Feature in Azhal keel vayu 
      
 Pranan 
 
 
Maintain the cardiac 
function,respiration 
 
Normal 
 
Abanan 
Act with downward 
movement 
Constipation present 
Viyanan 
 
Helps in various movements 
of body, responsible for 
sensation 
 
Restricted  movements of the 
joints 
 
 
 
Samanan Regulates all other vayus          Affected 
Nagan 
Responsible for intelligence 
Helps in opening and closing 
of eyes 
            Normal 
Koorman 
Responsible for lacrimation. 
Helps in visualization of all 
things of world 
In aged patients acuity of vision 
is diminished. 
Kirukaran 
 
Produce cough and 
sneeze,helps in digestion 
Normal 
 
Thevathathan 
 
 
Responsible for laziness, 
rotation of eye balls 
 
Sleeplessness due to pain 
 
 
Thananjeyan 
 
It leaves from the body by 
blowing up the cranium only 
on the 3rd day after death. 
_ 
 
 
 
 
 
 
Pittham 
 Pittham is a force of heat, God to all disease, mother to dasha vayukkal, 
assistant to boothas and responsible for fever. 
Anar pitham 
Digests all the ingested 
particles 
Affected 
Ranjaga pitham 
Increase the blood and gives 
colours to blood 
Affected 
Saathaga pitham 
Makes the work to complete 
what mind thinks to do 
Affected. 
 restricted movement 
Aalosaga pitham 
Responsible for vision of 
eyes 
Affected in old age 
people 
Prasaga pitham Gives colours to skin Not affected. 
 
 
Kabam 
It is classified into five types 
Avalampagam Controls other 4 types of kabam Affected  
Kilethagam Moistness the food Affected 
Pothagam 
 
Tharpagam 
Helps to know the taste 
 
Gives cooling  to the eyes 
Normal 
 
               Normal  
Santhigam Gives lubrication of joint Affected 
 
 
 
 
Udal Thathukkal 
 There are seven udal thathukkal in human body. 
Saaram Strengthens the body and mind Affected 
Senneer 
Preserves brightness, boldness 
power and knowledge 
Affected 
Oon 
Gives structure and shape to 
body. Responsible for movement 
Early stage – not 
affected. 
Later stage – Affected 
Kozhuppu Lubricate the joints Affected 
Enbu Responsible for joint movement Affected 
Moolai 
It is present in the bones and 
gives strength 
Affected 
Sukkilam or 
Suronitham 
Meant for reproduction Normal 
 
DIFFERENTIAL DIAGNOSIS : 
1) AGATHIYAR AYUL VETHAM-1200 
“Koq;fhy; tPq;fpf; fLj;J nehe;J Nkhjpj;jpuz;L Ntjidaha; 
toq;fhnjd;d eilfl;L tUj;jkpfTe; jhDKz;lha;”  
     -mfj;jpah; MAs;Ntjk; 1200 ghly; 296. 
2) THERAIYAR VAGADAM 
“Koq;fhy; thjq;fdj;J tPf;fkhfp Krpahky; 
fLj;J elf;nfhl;lhnjd;W” 
-Njiuah;thfk; ghly; 217. 
 
 
3) PARA RASA SEKARAM –VATHA ROGA NITHANA CHIKITCHAI  
“jpuz;bL Koq;fhy; tPq;fpr; Nru nehe;Jise;J Fj;jpg;  
Guz;bl klf;fp kpz;bg; NghjNt eilnfhlhJ 
kUz;LNty; fizkhdk;G thnsd kpspUq;fz;zha; 
Kuz;lU Koq;fhy; jd;dpd; nkhope;JL thjkhNk” 
-guuhrNrfuk; ghly; 182 
4) NARI VATHAM : “ele;jpbd; Koq;fhy; tPq;fp eLf;nfd Fj;jp thq;fpj;  
Jlh;e;Jld; gpbj;J kpz;bj; Jbj;JldLf;fKz;lhk; 
mlh;e;jpLk; tapw;W Nehth ajpfkha;j; jpuz;NlaWk; 
glh;e;jpL ehpthjj;jpd; Fznkdg; gfh;e;jhud;Nw” 
- guuhr Nrfuk; thjNuhfk; ghly; 209. 
 
5) NARITHTHALAI VATHAM : 
%h;f;fkh Kad;W Koq;fhy;jhd; tPq;fp Kjph;e;J  
       uj;jKe;jpuz;L Kaw;rpahfp  
epf;fkha; epd;wpl nthzkw; jhZk; epkph;e;jpLfpy;  
       re;Jjhd; Klf;nfhzhky; 
jPh;f;fkha; Jz;bj;J kpfr;rpf;nfd;W nrOik  
       ehpj;jiyNghy kpfNt tPq;fp 
ehh;f;fkha; ehbANk glglf;Fk; ehpj;jiyapd;  
 
 
       thjnkd;Nw etpyyhNk” 
-A+fpitj;jpa rpe;jhkzp800  ghly; 263. 
 
6) UTHIRA VATHA SURONITHAM : 
“itfpjkha;f; fizf;fhY Koq;fhy; jhDk;  
      kw;fhlQ;re;J GwtbAk; tPq;fpr; 
nra;fpjkhQ; rpWtpuy;fs; kpfTk; nehe;J rpe;ij 
       jLkhwpNarypg;Gz;lhFk; 
igfpjkhk; jLkhwpNa rypg;Gz;lhFk; ghuhkha; cw;gtpj;J moYz;lhFk; 
ca;fpjkhk; mrdJ jhDk; Ntz;lh cjputhjr; RNuhzpjj;jp  
                                          Dzh;r;rpahNk” 
-A+fp itj;jpa rpe;jhkzp 800 ghly;:319 
7) PAYITHIYA VATHA SURONITHAM : 
“czh;r;rpaha;r; RNuhzpje;jhd; kpfntJk;gp Cf;fkha;j; Njnkq;Fk;  
                                            kpfNtnehe;J 
Kzh;r;rpah Koq;fhy;fs; Koq;ifnahf;f Kidahd rpWtpuy;fs;  
                                           fd;dk;new;wp 
jzh;r;rpaha;r; re;J rUthq;fnkq;Fk; jhl;bfkha;f; File;J RuKKz;lhk; 
gzh;r;rpaha; ghz;lJ Nghd;NkdpahFk; gapj;jpathj RNuhzpjj;jpd;  
          gz;GjhNd” 
- A+fp itj;jpa rpe;jhkzp 800 ghly;:320 
 
 
8) MEGA VATHAM : 
“Klf;fpNa Koq;fhy; tPq;fp Kjph;ry Nkhjha; tPOk;  
jlf;fpNa eilnfhlhJ je;JNghw; rpaYKz;lhk; 
tPlf;fay; tLkhdk;G Ntnyd kpspUq;fz;zha; 
klf;fpa NkfthjQ; nra;Fzk; tFf;fyhNk” 
- guuhrNrfuk; thjNuhfk; ghly;-197. 
9) SURONITHA SILETPAM : “cz;ikaha; Koq;fhypy; kpff;File;J cise;JNk KJNfhL 
        tpyhg;gf;fq;fs; 
fz;ikaha; Koq;iffs; Koq;ifr;re;J fbdkha; tPq;fpNa  
        Filr;rYz;lhk; 
jz;ikaha; rspf;fl;Lj; jhfkhFk; rhjfkha; ,UkpNa %r;Rz;lhFk; 
jpz;ikaha; ehtuz;L rpj;jpg;ghFk; nrakhd RNuhzpj rpNyl;ge;jhNd” 
- A+fp itj;jpa rpe;jhkzp ghly; 415. 
10) MUZHAANKALAL VATHAM : 
“ jpuz;bL Koq;fhy; tPq;fpr; Nru nehe;Jise;J Fj;jpa; 
Guz;bl klf;fp kpz;bg; NghjNt eilnfhlhJ 
kUz;LNty; fizkhdk;G thnsd kpspUq;fz;zha; 
Kuz;lU Koq;fhy; jd;dpd; nkhope;JU thjkhNk”. 
- guuhrNrfuk; ghly;-182. 
 
 
 
PINIYARI MURAIMAI(DIAGNOSIS) 
 Piniyari muraimai is the methodology of diagnosing the disease in siddha 
system.  
Envagai therugal: 
'ehb ];ghprk; eh epwk; nkhop tpop 
kyk; %j;jpukpit kUj;Jt uhAjk;" 
• Naadi(Pulse) 
• Sparisam (sense of touch) 
• Naa(Tongue) 
• Niram(Colour) 
• Mozhi(Speech) 
• Vizhi(Eyes) 
• Malam(Stool) 
• Moothiram(Urine) 
'nka;f;Fwp epwe;njhzp tpop ehtpUkyk; iff;Fwp" 
1.Naadi (Pulse) 
 This is a unique diagnostic method in siddha system of medicine. It is 
responsible for existence of life. It is felt one inch below the wrist on the 
radial side by palpatcing with the top of the index finger, middle finger and 
ring finger which denotes vatham, pitham and kabam. 
Suitable places for pulse reading: 
 'jhJ KiwNfs; jdpFjpr; re;njhL 
 
 
 XJW fhkpa Ke;jp neL khu;G 
 fhJ neL%f;Ff; fz;lk; fuk; GUtk; 
 NghJU cr;rp Gfo; gj;Jk; ghu;j;jpNl" 
2.Sparisam(Sense of Touch): 
 The abnormal increased sparisam is clinically called as inflammatory 
changes. 
 Increased sparisam-Mithaveppam(warmth) felt on affected joints in 
Azhal keel vaayu. 
3.Naa (Tongue): 
 Vadha disease Dark in colour 
 Pitha disease Yellow in colour 
 Kaba disease  White colour 
In Azhal keel vaayu dark & dried tongue may be seen. 
4.Niram (Colour): 
 The colour of the affected part and general colour of the body may be 
altered depends upon the severity of the disease. 
 In Azhal keel vaayu the affected to in red in colour. 
5.Mozhi (Speech): 
 Speech will be affected in Vadha disease because of Piranan, Uthanan, 
Kirugaran and Devathathan are disturbed. 
 In Azhal keel vaayu decreased tone of speech because of the severity of 
disease. 
 
 
6.Vizhi (Eyes): 
 Normaly vizhi affected in old age. In Azhal keel vaayu most commonly 
affected in elderly people. 
7.Malam (Stools): 
 Constripation common is Vadha disease. In Azhal keel vaayu malam may 
be affected. 
8.Moothiram (Urine): 
 The waste materials are executed through urine from the body. 
 In Azhal keel vaayu there will no specific change in neerkuri. 
NEERKURI-NEIKURI: 
 In siddha system of medicine changes of urine is studied under two. 
Peculiar headings. They are”Neerkuri and Neikuri”: 
 'te;j ePu;f;fup vil kzk; vQ;rnyd; 
 iwe;jpaYit aiwFJ KiwNa" 
     - Njuu; ePu;Fwp - nea;Fwp  
 
Neikuri: 
• mwntd ePz;bd/Nj thjk;  
• MopNghw; gutpd; m/Nj gpj;jk; 
• Kj;njhj;J epw;fpd; nkhoptnjd fgk;  
     - Njuu; ePu;Fwp - nea;Fwp  
 
 
This procedure is an important one in siddha system of medicine to find out the 
diagnosis as well as in prognosis aspect of the disease. So disease in man do not 
originate itself. It is developed from the alteration of three dhoses. 
LINE OF TREATMENT 
 In Siddha system the main aim of the treatment is to cure Udar pini (due 
to Mukkutram) and Manapini (due to changes in Mukkunam). Treatment is not 
only for perfect healing but also for the prevention and rejuvenation. 
Line of Treatment is as follows: 
 1.  Prevention 
 2. Treatment 
Prevention : 
 The prevention methods for Azhal keel vaayu are as follows: 
 1. Control the body weight. 
 2. Modify the nature of work. 
  eg. Avoid prolonged standing and long distance walking. 
 3. Avoid excess intake of high coloric foods. 
 
Treatment : 
 The aim of Neekkam is based on 
 To bring the deranged dhosams to normal equilibrium state. 
 First the deranged dhosams has to be brought to its normal state by giving 
Virechanam or Vamanam or Nasiyam. 
 
 
1. Purgative : 
'tpNurdj;jhy; thje; jhOk;" 
 In Azhal keel vaayu, vatha kuttram is deranged. So a purgative vellai 
ennai - 15 ml with hot water in early morning in empty stomach on the first day 
is given. 
2. Internal Medicine : 
 Karungozhi Chooranam - 1.5gm / daily with hot water. 
3. External Medicine : 
 Vidamutti thylam - External application. 
4. Complementary Therapies : 
 There are enormous complementary therapies followed in Siddha system 
of medicine such as kattu, pattru, Nasiyam, Attai Vidal, Thokkanam, Ottradam, 
Varmam, Asanam, Vedhu etc. 
COMPLEMENTARY THERAPIES: 
I Thokkanam (Massage) 
II Ottradam (Fomentation 
III Kattu (Bandage) 
IV Varmam 
V Aasanam 
I Thokkanam : 
 Massage is the manipulating of superficial and deeper layers of muscle 
and connective tissue using various techniques, to enhance function, aid in the 
 
 
healing process, decrease muscle reflex activity, inhibits motor neuron activity 
and promotes relaxation and well being massage can be applied with the hands, 
fingers, elbows, knees, forearm and feet. 
II  Ottradam (fomentation) 
  Its is application of the hot or cold substances applied through packages 
In siddha literature lot of ottradam describe 2 types  of otttradam applied in my 
study  
I.Hot Formentation by medicated pouches  
 Dried leaf of nottri (ritex negundo) Thaluthalai Manjanathi (Moinda 
tinctoria ) erukku (calotropis gigantean) which is stuffed in a cleaned doth it is 
tied tightly. 
II.Hot Formentation by lemon  
 In this method lemon is cutted hafly Each pieck of lemon tied by a cloth 
and it is dipped in  the hot trial drug and applied on the affected joints  
III  Kattu (Bandage) 
 The fresh Aadathodai ( Justicia adathoda ) leaves are made into pieces 
and it is mixed with external medicine This Kept in a piece of cotton and 
wrapped  
 
 
 
 
 
 
 
 
THOKKANAM 
 
 
 
 
 
 
  
 
 
FOMENTATION BY LEMON 
 
FOMENTATION BY MEDICATED POUCHES 
 
 
  
 
 
IV  Varmam: 
Varmam points to be manipulated for osteoarthrosis are as follows 
1. Mootu varmam :  Centre part of posterior apsect of both knee 
joints. Mild pressure is applied using tips of middle three fingers. 
2. Kuthiraimuga varmam 
Location – Tibial tuberosity  
Pressure is applied for three time using bulb of thumb. 
3. Mootu Suzharchi 
This method stimulates varmam points around knee joint by a 
circulatory gripping massage around patella using thumb and index 
finger. 
4. Santhuvarmam :  
Location : on either side of the mootu varmam 
5. Sirattai varmam :   
Location : on the patella bone. 
6. Mozhi poruthu varmam:  
Location :  Posterior surface of the knee joint  
7. Asaivu thiru kannu varmam: 
Location :  In centre of anterior surface, 2 finger breadth 
sidewards to the knee joint. 
8. Pathaippu Varmam: 
Location :  6 finger breadth lateral to the patella. 
 
 
 
 
V. Asanam : 
 Yogasanas are the well known procedures followed by our great siddhars 
for both preventing the body from degeneration and for curing and regenerate 
the body from ailments. Yogasana are followed as one of the important 
complementary therapy in the line of treatment for many diseases which are 
practiced worldwide now-a-days. 
Padmasanam : 
 1. Fold the left leg in the knee and place the left foot against the right 
thigh. 
 
 
 2. Similarly fold the right leg in the knee and place the right feet on 
the left thigh. 
 3. Place the hands on the respective knees with case and sit erect. 
Ukatasanam : 
 Stretch your arms, lengthen the spine and bend your knees and move your 
trunk forward at 45 degrees. 
 
 
 
 It usually strengthens the muscles of the legs particularly the quadriceps 
femoris. 
Vajrasanam : 
 Fold both the knees, keep the joint with each other and sit on the pit 
formed by the heels, keep the spine, neck and head straight. 
 
 
 This pose increases the flexibility of the knee joint and reduces the 
stiffness of the knee joint. 
Garudasanam : 
1. From Ukatasanam shift your weight on the left leg. 
2. Bend the right leg, lifting the foot from the floor and cross your 
right thigh over your left. 
3. Take the right foot around the left calf. 
 
 
4. Bring the arms out in front. 
5. Cross the left arm over the right and bring the palms to touch. 
6. Lift the elbows while keeping the shoulders sliding down the back. 
7. Hold 5-10 breaths. 
8. Repeat on the other side. 
 Strengthens legs, improves balance and strengthens the shoulder.  
 
 
MODERN ASPECT 
ANATOMY OF THE KNEE JOINT 
-Synovial joint 
-Modified hinge joint 
-Compound joint 
Articulation : 
 It is a compound joint that includes two condylar joints between the 
femur and the tibia and a sellar joint between the patella and the femur. 
 The lateral and medial articular surface of the femur and tibia are 
asymmetrical. The distal surface of the medial  condyle of the femur is narrow 
and more curved than that of the lateral condyle. 
 The lateral tibial articular surface is almost  circular the medial is oval 
with  a longer anteroposterior and these differences are reflected in the shape of 
the menisci. The articular surface of the patella is divided by  vertical ridge into 
a large lateral and a small medial surface, the latter is further subdivided by a 
vertical ridge into two smaller areas. 
LIGAMENTS: 
1. FIBROUS CAPSULE 
 The   fibrous  capsule   is  very  thin  and  is  deficient   anteriorly,  where  
it  is  replaced  by  the  quadriceps  femoris, the  patella  and  the  ligamentum      
patellae.   The  capsular  ligament  is  weak. it  is strengthened  anteriorly  by  
the  medial  and lateral  patellar  retinacula  which  are  extensions  from  the  
vastus   medialis  and  lateralis.  Laterally  by the  iliotibial   tract,  medially  by  
 
 
expansions  from  the  tendons  of  the  sartorius  and  semimembranosus  and  
posteriorly  by  the  oblique  popliteal  ligament                                                        
 2. LIGAMENTUM  PATELLAE                                                                                                                          
  It  is  attached  above  to  the  margin  and  rough  posterior  surface  of  
the  apex   of  patella  and  below  to  the  smooth  upper  part  of  the  tibial  
tuberosity.          
3. TIBIAL  COLLATERAL  LIGAMENT                                                                                                                            
It  is   a  flat,  triangular   band  attached  above   to  the  medial   femoral   
epicondyle,    just   distal to the adductor tubercle and attached below to the 
upper part of the medial surface of the tibia. 
4. FIBULAR COLLATERAL LIGAMENT: 
 The ligament is strong and cord- like. It is attached proximally to the 
lateral epicondyle below the attachment of the lateral head of gastrocnemius and 
above that of the tendon of popliteus. Its distal attachment is to head of the 
fibula overlapped by the tendon of biceps femoris. 
5.  OBLIQUE POPLITEAL LIGAMENT: 
 It is an expansion from the tendon of semimembranosus that blends with 
the capsule at the back of the joint and ascends laterally to the intercondylar 
fossa and lateral femoral condyle. 
6. ARCUATE POPLITEAL LIGAMENT: 
 It is a Y shaped posterior expansion from the short lateral ligament.  It 
extends backwards from the head of the fibula, arches over the tendon of the 
popliteus and is attached to the posterior border of the intercondylar area of the 
tibia. 
 
 
7-8 CRUCIATE LIGAMENTS: 
 Anterior and posterior cruciate ligaments connecting tibia to femur.  
These are very thick and strong fibrous bands which act as direct bonds of union 
between tibia and femur to maintain anteroposterior stability of knee joint. 
9.10 MENISCI: 
 a) Medical menisci:- 
  Semicircle and is broader posteriorly.  It is firmly attached to the 
capsule and tibial collateral ligament. 
 b) Lateral menisci: 
  It is about four-fifths of circle and is of uniform width.  Its anterior 
horn is attached in front of the intercondylar eminence of the tibia.  The 
posterior horn is attached behind the intercondylar eminence, in front of the 
posterior horn of medial meniscus. 
11.  TRANSVERSE LIGAMENT: 
 It connects the anterior ends of the medial and lateral menisci. 
 SYNOVIAL MEMBRANE: 
  It is the most extensive in the body but the amount of synovial fluid 
in a normal joint is only 0.5ml. a mere capillary film.  The synovial membrane 
of the knee joint lines the capsule, except posteriorly where it is reflected 
forwards by the cruciate ligaments, forming a common covering for both  
ligaments. 
Attachments : 
                           In front, it is absent from the patella.  Above the patella, it is 
prolonged upwards for 5 cm or more as the suprapatellar bursa. Below the 
 
 
patella, it covers the deep surface of the infrapatellar pad of fat, which separates 
it from the ligamentum patellae. A median fold, the infrapatellar  synovial fold, 
extends backwards from the pad of fat to the intracondylar fossa of the femur. 
An alar fold diverges on each side from the medial fold to reach the lateral 
edges of the patella. 
 
Bursae around  the knee: 
Anterior: 
• Subcutaneous prepatellar bursa 
• Subcutaneous infrapatellar bursa 
• Deep infrapatellar bursa 
• Suprapatellar bursa. 
 
 
Lateral: 
• A bursa deep to the lateral head of the gastrocnemius 
• A bursa between the FCL and the biceps femoris 
• A burse between the FCL and popliteus tendon. 
• A bursa between the popliteus tendon and lateral condyle of the tibia  
Medial: 
 1.Bursa deep to the medial head of the gastrocnemius 
 2. Anserine bursa 
 3. Bursa deep to TCL 
 4. Bursa deep to the semimembranosus. 
 5. Occassionally a bursa is present between the tendon of the 
semimembranosus and the semitendinosus  
BLOOD SUPPLY: 
• Five genicular branches of the politieal artery. 
• Descending genicular branch of the femoral artery 
• Descending branch of the lateral circumflex femoral artery 
• Two recurrent branches of the anterior tibial artery 
• Circumflex fibular branch of the posterior tibial artery. 
NERVE SUPPLY: 
 Femoral nerve 
 Sciatic nerve 
 Obturator nerve 
 
 
                            ARTHRITIS OF KNEE  
Osteoarthritis(Osteo arthritis) is the most common form of knee arthritis. 
Osteo arthritis is usually a slowly progressive degenerative disease in which the 
joint cartilage gradually wears away. It most often affects middle-aged  older 
people. 
EPIDEMIOLOGY AND RISK FACTORS 
Osteo arthritis is the most common joint disease of humans. Among the 
elderly, knee Osteo arthritis is the leading cause of chronic disability in 
developed countries. Radiographic evidence of knee Osteo arthritis and 
especially symptomatic knee Osteo arthritis, is more common in women than in 
men. 
Age is the most powerful risk factor for Osteo arthritis. In a radiographic 
survey of women less than 45 years old, only 2% had Osteo arthritis; between 
the ages of 45 to 64 years, however the prevalence was 30% and for those older 
than 65 years it was 68%. In males, the figures were similar but somewhat 
lower in the older age groups. 
Major trauma and repetitive joint use are also important risk factors for 
Osteo arthritis. Anterior cruciate ligament insufficiency or meniscus damage 
and meniscetomy may lead to knee Osteo arthritis. Although damage to the 
articular cartilage may occur at the time of injury or subsequently, with use of 
the affected joint, even normal cartilage will degenerate if the joint is unstable. 
TYPES OF Osteo arthritis 
 Osteoarthritis can be broadly grouped as follows: 
  *Primary osteoarthritis when there is no previous pathology.  
 
 
  *Secondary osteoarthritis when it is secondary to some previous 
pathology. 
Primary Osteoarthritis 
 Primary osteoarthritis is due to the wear and tear changes occurring in old 
age in which weight bearing joints like the hips and knees are more commonly 
affected. It is uncommon in non-weight bearing joints like the shoulder and 
elbow.Obesity is a predisposing factor. 
Osteoarthritis is a progressive process affecting the articular cartilage of 
aging joints. It is characterised by focal degeneration of the articular cartilage. 
As the articular cartilage is cyclically loaded during movements of joints, it 
undergoes fatigue failure leading to fragmentation of the surface and fibrillation. 
In the later stage, the cartilage gets completely eroded, exposing the 
sclerosed(eburnated) bone and subchondral cysts are also formed.  
The bone undergoes reactive hypertrophy forming peripheral osteophytes. 
The synovial membrane undergoes hyperemia and reactive inflammatory 
thickening. As there is no destructive pathology, the joint dose not get 
ankylosed.  
Secondary Osteoarthritis 
  Secondary osteoarthritis is due to an abnormal wear and tear in a joint, 
caused by mechanical incongruity of the articular surfaces. This incongruity 
may be the result of a preceding fracture involving the articular surface or 
partial destruction or deformity due to a previous disease. 
 
 
 
 
 
Aetiology 
The causes of osteoarthritis include the following: 
• Endocrine: People with diabetes may prone to osteoarthritis. Other 
endocrine problems also may promote development, including 
acromegaly, hypothyroidism, hyperparathyroidism and obesity. 
• Post traumatic: Traumatic causes can be further divided into 
macrotrauma. An example of macrotrauma is an injury to the joint such 
as bone break, causing the bones to line up improperly,  lose stability or 
damage cartilage. Microtrauma may occur  chronically. An example of 
this would be repetitive movements or the overuse noted in several 
occupations. 
• Inflammatory joint diseases: This category would include infected joints, 
chronic gout and rheumatoid disease. 
• Metabolic: Diseases causing errors of metabolism may cause 
osteoarthritis. Examples include Paget’s disease and Wilson disease. 
• Congenital or Developmental: Abnormal anatomy such as unequal leg 
length may be a cause of osteoarthritis. 
• Genetic: A genetic defect may promote breakdown of the protective 
architecture of cartilage. Examples include collagen disturbances such as 
Ehlers-Danlos syndrome. 
• Neuropathic: Diseases such as diabetes can cause nerve problems.  
• Other: Nutritional problems may cause osteoarthritis. Other diseases such 
as hemophilia and sickle cell are further examples.  
 
 
 
    PATHOGENESIS 
 The main load on articular cartilage- the major target tissue Osteo 
arthritis is  produced by contraction of the muscles that stabilize or move the 
joint. 
Although cartilage is an excellent shock absorber in terms of its bulk properties, 
at most sites it is only 1 to 2 mm thick- too thin to serve as the sole shock- 
absorbing structure in the joint.Additional protective mechanisms are provided 
by subchondral bone and periarticular muscles. 
 Articular cartilage serves two essential functions within the joint, both of 
which are mechanical. First, it provides a remarkably smooth bearing surface, 
so that the bones glide effortlessly over each other with joint movement. With 
synovial fluid as lubricant, the coefficient of friction for cartilage rubbed against 
cartilage even under physiologic loading, is 15 times lower than that of two ice 
cubes passed across each other. Second, articular cartilage prevents the 
concentration of stresses, so the bones do not shatter when the joint is loaded. 
 Osteo arthritis develops in either of two settings: 
• The biomaterial properties of the articular cartilage and subchondral bone 
are normal, but excessive loading of the joint causes the tissues to fail, or 
• The applied load is reasonable, but the material properties of the cartilage 
or bone are inferior. 
 Although articular cartilage is highly resistant to wear under conditions of 
repeated oscillation,repetitive impact loading soon leads to joint failure. This 
fact accounts for the high prevalence of Osteo arthritis at specific sites related to 
vocational or  avocational overloading. In general, the earliest changes occur at 
the sites in the joint that are subject to the greatest compressive loads.  
 
 
 Clinical conditions that reduce the ability of the cartilage or subchondral 
bone to deform are associated with development of Osteo arthritis. In ochronsis, 
for example, accumulation of homogenitisic acid polymers leads to stiffening of 
the cartilage; in osteopetrosis, stiffness of the subchondral trabeculae. In both 
conditions, severe generalized Osteo arthritis is usually apparent by the age of 
40.If the subchondral bone is stiffened experimentally, repetitive impact loading 
soon leads to breakdown of the overlying cartilage. Conversely, osteoporosis, in 
which bone is abnormally soft, may protect against Osteo arthritis. 
The Extracellular Matrix of Normal Articular cartilage 
 Articular cartilage is composed of two major macromolecular species: 
proteoglycans(PGs), which are responsible for the compressive stiffness of the 
tissue and its ability to withstand load and collagen, which provides tensile 
strength and resistance to shear. Although lysosomal proteases(cathepsins) have 
been domonstrated within the cells and matrix of  normal articular cartilage, 
their low pH optimum makes it likely that the proteoglycanase activity of these 
enzymes will be confined to intracellular sites or the immediate pericellular 
area. However, cartilage also contains a family of matrix metalloproteinases 
(MMPs), including stromelysin, collagenase and gelatinase, which can degrade 
all the components of the extracelluler matrix at neutral pH. Each is secreted by 
the chondrocyte as a latent proenzyme that must be activated  by proteolytic 
cleavage of its N-terminal sequence. The level of MMP activity in the cartilage 
at any given time represents the balance between activation of the proenzyme 
and inhibition of the active enzyme by tissue inhibitors. Much of the total tissue 
pool of aggrecan, the major PG in articular cartilage, is degraded by a 
proteinase, which cleaves the protein core of a molecule at a site distinct from 
the cleavage site of the MMP . The enzyme responsible for this cleavage is 
referred to as “aggrecanase” but has not been clearly identified. 
 
 
 The turnover of normal cartilage is effected through a degradative 
cascade, for which many investigators consider the drivingforce appears  to be 
interleukin(IL) 1, a cytokine produced by mononuclear cells (including synovial 
lining cells) and synthesized by chondrocytes. IL-1 stimulates the synthesis and 
secretion of the latent MMPs and of tissue plasminogen activator. Plasminogen, 
the substrate for the latter enzyme, may be synthesized by the chondrocyte or 
may enter the cartilage from the synovial fluid. Both plasminogen and 
stromelysin may play a role in activation of the latent MMPs. In addition to its 
catabolic effect on cartilage, IL-1, at concentrations even lower than those 
needed to stimulate cartilage degradation, suppresses PG synthesis by the 
chondrocyte, inhibiting matrix repair. 
 The balance of the system lies with at least two inhibitors, tissue inhibitor 
of metalloproteinase(TIMP) and plasminogen activator inhibitor-1 (PAI-1), 
which are synthesized by the chondrocyte and limit the degradative activity of 
MMPs and plasminogen activator, respectively. If TIMP or PAI-1 is destroyed 
or is present in concentrations that are insufficient relative to those of active 
enzymes, stromelysin and plasmin are free to act on matrix substrates. 
Stromelysin can degrade the protein core of the PG and activate latent 
collagense. Conversion of latent stromelysin to an active, highly destructive 
protease by plasmin provides a second mechanism for matrix degradation. 
 Polypeptide mediators, e.g., insulin-like growth factor-1(IGF-1) and 
transforming growth factor (TGF-β), stimulate biosynthesis of PGs.They 
regualate matrix metabolism in normal cartilage and may play a role in matrix 
repair in Osteo arthritis. Notably, these growth - modulate catabolic as well as 
anabolic pathways of chondrocyte metabolism; by down-regulating chondrocyte 
receptors for IL-1, they may decrease PG degradation. 
 
 
 In addition to its responsiveness to cytokines and a variety of  biologic 
mediators,  chondrocyte metabolism in normal cartilage can be modulated 
directly by mechanical loading. Whereas static loading and prolonged cyclic 
loading inhibit synthesis of PGs and protein, loads of relatively brief duration 
may stimulate matrix biosynthesis. 
Pathophysioloy of Cartilage Changes in Osteo arthritis 
 The primary changes in Osteo arthritis begin in the cartilage. A change in 
the arrangement and size of the collagen fibers is apparent. Biochemical data are 
consistent with presense of a defect in the collagen network of the matrix, 
perhaps due to disruption of the “glue” that binds adjacent fibers.This is among 
the earliest matrix changes observed and appears to be irreversible. 
 Although“wear” may be a factor in the loss of cartilage, strong evidence 
supports the concept that lysosomal enzymes and MMPs account for much of 
the loss of cartilage matrix in Osteo arthritis. Whether their synthesis and 
secretion or stimulated by IL-1 or by other factors(e.g., mechanical stimuli), 
MMPs, plasmin, and cathepsins all appear to be involved in the break down of 
articular cartilage in Osteo arthritis. TIMP and PAI-1 may work to stabilize the 
system, at least temporarily, while growth factors, such as IGF-1, TGF-β, and 
basic fibroblast growth factor, are implicated in repair processes they may heal 
the lesion or, at least, stabilize the process. A stoichiometric imbalance exists 
between the levels of active enzyme and the level of TIMP, which may be only 
modestly increased. 
 The possible role of nitric oxide (NO) in articular cartilage damage in 
Osteo arthritis, since NO has been shown to stimulate synthesis of MMPs by 
chrondrocytes. Chondrocytes are a major source of NO, synthesis of which is 
stimulated by IL-1 and tumor necrosis factor and by shear stresses on the tissue. 
 
 
In an experimental model of Osteo arthritis, treatment with a selective inhibitor 
of inducible NO synthase reduced the severity of cartilage damage. 
 The chondrocytes in Osteo arthritis cartilage undergo active cell divison 
and very active metabolically, producing increased quantities of DNA,RNA 
collagen, PG and noncollagenous proteins. Prior to cartilage loss and PG 
depletion, this marked biosynthetic activity may lead to an increase in PG 
concentration, which may associated with thickening of the cartilage and stage 
of homeostasis referred to as “compensated” Osteo arthritis. These mechanisms 
may maintain the joint in a reasonably functional state for years. The repair 
tissue, however, often does not hold up as well under mechanical stresses as 
normal hyaline cartilge end eventually, at least in some cases, the rate of PG 
synthesis falls off and “end-stage” Osteo arthritis develops, with full-thickness 
loss of cartilage. 
CHANGES  OF NORMAL CARTILAGE TO AGING CARTILAGE: 
          In normal articular cartilage aggrecan contains numerous GAG which  is 
capable of retaining water. 
          Several structural and biochemical changes involving the non collagenous 
component of the matrix occur during aging. These changes alter biochemical 
properties of the cartilage that are essential  for the distribution of forces in the 
weight bearing zone. 
         Glycosaminoglycans are modified qualitatively; they become shorters as 
the cartilage ages. The concentration of kertain sulphate increase during aging. 
          These quantitative and qualitative changes in proteologlycans reduce the 
capacity of the molecules to retain water. Thus aging cartilage contains less 
water, which alters the biochemical properties of the cartilage. Fissures that 
develop aging are due to stress fractures of the collgen network. 
 
 
CLINICAL FEATURES 
 The joint pain of Osteo arthritis is often described as a deep ache and is 
localized to the involved joint. Typically, the pain of Osteo arthritis is 
aggrevated by joint use and relieved by rest, but as the disease progresses, it 
may become persistent. Nocturnal pain , interfering with sleep, is seen 
particularly in advanced Osteo arthritis of the hip and may be enervating. 
Stiffness of the involved joint upon arising in the morning or after a period of 
inactivity (e.g.,a night’s sleep ,an automobile ride) may be prominent but 
usually lasts less than 20 min. Systemic manifestations are not a feature of 
primary Osteo arthritis. 
 Because articular cartilage is aneural, the joint pain in Osteo arthritis must 
arise from other structures . In some cases it may be due to stretching of nerve 
endings in the periosteum covering osteophytes; in others, to microfractures in 
subchondral bone or from medullary hypertension caused by distortion of blood 
flow by thickened subchrondral trabecule. Joint instability, leading to stretching 
of the joint capsule and muscle spasm may also be sources of pain. 
 In some patients with Osteo arthritis, joint pain may be due to synovitis. 
In advanced Osteo arthritis, histologic evidence of synovial inflammation may 
be as marked as that in the synovium of a patient with rhumatoid arthritis. 
Synovitis in Osteo arthritis may be due to phagocytosis of shards of cartilage 
and bone from the abraded joint surface (wear particles), to release from the 
cartilage of soluble matrix macromolecules, or to crystals of calcium 
pyrophosphate or hydroxyapatite. In other cases, immune complexes, containing 
antigens derived from cartilage matrix, may be sequestered in collagenous tissue 
of the joint, leading to low grade chronic synovitis. In contrast, in the earlier 
stages of Osteo arthritis, even in the patient with chronic joint pain, synovial 
 
 
inflammation may be absent, suggesting that the joint pain is due to one of the 
other factors mentioned above. 
 Physical examination of the Osteo arthritis joint may reveal localized 
tenderness and bony or soft tissue swelling. Bony crepitus (the sensation of 
bone rubbing against bone, evoked by joint movement) is characteristic. 
Synovial effusions, if present, are usually not large. Palpation may reveal some 
warmth over the joint. Periarticular muscle atrophy may be due to disuse or  
reflex inhibition of muscle contraction. In the advanced stages of Osteo arthritis, 
there may be gross deformity, bony hypertrophy, subluxation, and marked loss 
of joint motion. In many patients the disease stablizes; in some, regression of 
joint pain and even of radiographic changes occurs. 
 Although the diagnosis of Osteo arthritis is often straightforward because 
of the high prevalence of radiographic changes of Osteo arthritis in 
asymptomatic individuals, it is important to ensure that joint pain in a patient 
with radiographic evidence of Osteo arthritis is not due to some other cause, 
such as soft tissue rheumatism (e.g., anserine bursitis at the knee, trochanteric 
bursitis at the hip), radiculopathy, referral of pain from another joint (e.g., 25% 
of patients with hip disease have pain referred to the knee), entrapment 
neuropathy, vascular disease(claudication), or some other type of arthritis (e.g., 
crystal-induced synovitis, septic arthritis). It is usually not difficult to 
differentiate Osteo arthritis from a systemic rheumatic diseases, joint 
involvement is rhumatroid arthritis, because, in the latter diseases, joint 
involvement is usually symmetric and polyarticular, with arthritis in wrists and 
metacarpophalangeal joints (which are generally not involved in Osteo 
arthritis),and there are also constitutional features such as prolonged morning 
stiffness, fatigue, weight loss or fever. 
 
 
 
Causes of joint pain in patients with Osteo arthritis 
Source     mechanism 
Synovium     inflammation 
Subchondral bone medullary hypertension, 
microfractures 
Osteophyte Stretching of periosteal nerve 
endings 
Ligaments stretch 
Capsule   Inflammation, distention 
Muscle   spasm                               
                                                          
Diagnosis 
Imaging 
• X-rays:  
     Approximately one-third of people with osteoarthritis on X-rays have 
symptoms such as pain or swelling. X-rays can show narrowing of the space 
between the joint (articular surface), osteophytes, cyst formation, and hardening 
of the underlying bone. Scoring systems have been used to assess the extent of 
the bony changes on X-rays. Separate scoring systems for the different joints 
have been studied and found to be predictive of disease status. An important 
finding from these studies was that the presence of osteoarthritis of the hands 
was a predictive sign of deterioration of the knee joint. 
 
 
 
 
• MRI :  
       This study is complex, noninvasive imaging technique that unlike X-
rays. X-rays provide information mainly bones. However, MRI is capable of 
visualizing all structures within the joint.  
• CT scan : 
              This study may be used to image a joint. CT scanning mainly provides 
information on the bony structures of the joint but in greater detail than plain X-
rays. 
• Joint Fluid Analysis : 
             Fluid may be extracted from the knee with a needle and syringe when 
the diagnosis is uncertain or if an infection is suspected. 
Blood Tests : 
            No currently accepted blood test marker for this disease exists. Blood 
tests may be drawn in cases in which infection is suspected. 
Osteoarthritis Differential Diagnosis 
• Rhumatoid arthritis 
• Spondyloarthropathy 
• Chondrocalcinosis 
• Joint trauma 
• Metabolic Bone Disorders 
• Hypermobility syndromes 
• Neuropathic diseases 
 
 
The following should also be considered in the differential diagnosis: 
• Crystal deposition disease 
• Pseudogout 
• Inflammatory arthritis 
• Seronegative spondyloarthropathies 
• Infected joint 
• Underlying mechanical pain 
• Reactive arthritis 
Differential Diagnoses : 
• Abdominal Aortic Aneurysm Imaging 
• Ankylosing Spondylitis 
• Avascular Necrosis 
• Calcium Pyrophosphate Deposition Disease 
• Imaging in Neuropathic Arthropathy(Charcot joint) 
• Lyme Disease 
• Patellofemoral Arthritis 
• Patellofemoral Syndrome 
• Prepatellar Bursitis 
• Psoriatic Arthritis 
• Rhinosporidiosis 
 
 
Osteoarthritis Treatment: 
Self-Care at Home 
Lifestyle changes may delay or limit osteoarthritis symptoms. These are 
common home remedies: 
Weight loss: One study suggested that, for women, weight loss may reduce 
the risk for osteoarthritis in the knee. 
Exercise: Regular exercise may help to strengthen the muscles and 
potentially stimulate cartilage growth. Avoid high-impact sports. The 
following types of exercise are recommended: 
Range of motion, 
Strengthening 
Aerobic 
Diet: While there is no specific osteoarthritis diet, supplements of 
antioxidant vitamins C and E may provide some protection. Vitamin D and 
calcium are recommended daily. Dose of calcium is 1000-1200 mg per day. 
The current guideline for vitamin D is 400 IU per day. 
Heat: Hot soaks and warm wax(paraffin)application may relieve pain. 
Orthoses: These assistive devices, such as  or neck braces and knee braces, 
are used to improve function of movable parts of the body or to support, 
align, prevent, or correct deformities. Splints or braces help with joint 
alignment and weight redistribution. Other examples include walkers, 
crutches or canes and orthopedic footwear. 
Over-The-Counter(OTC)medications  
 Acetaminophen(tylenol) is the first drug recommended for osteoarthritis. 
 
 
Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used for 
arthritis pain.These include aspirin, ibuprofen(Motrin or Advil), 
naproxen(Aleve), and ketoprofen (Orudis). 
Newer OTC preparations include chondrotin and glucosamine sulfate, which 
are natural substances found in the joint fluid. Chondroitin is thought to 
promote an increase in the making of the building blocks of 
cartilage(collagen and proteoglycans) as well as having an anti-inflammatory 
effect. Glucosamine may also stimulate production of the building blocks of 
cartilage as well as being an anti-inflammatry agent. Glucosamine was found 
to increase blood sugar in animal studies, so people with diabetes should 
consult their doctor first. 
Arthritis self-help course: The Arthritis Foundation offers an educational 
program on the causes and treatment of arthritis. Exercise, nutrition, 
relaxation and pain management programs are covered as well as ways to 
communicate with your doctor. Completion of the program reduced pain by 
20% and doctor visits by 40%. 
Medical Treatment: The overall goal of treatment is early elimination of  
risk factors, early diagnosis and surveillance of the disease and appropriate 
treatment of pain. It’s also important to help people regain their mobility. 
Treatment These goals may be reached through a logical approach to care 
including the overlapping of treatment that does not involve medications and 
treatment with medication and possibly surgical management. 
Treatment that does not involve medications includes education, physical 
and occupational therapy, weight reduction, exercise and assistive 
devices(orthoses). 
 
 
 
Surgical Treatment 
      Joint replacement surgery should be reserved for patient with advanced 
Osteo arthritis in whom aggressive medical management has failed. In such 
cases total joint arthroplasty may be remarkable effective in relieving pain 
and increasing mobility.  
        Osteotomy, which  is surgically more conservative, can eliminate 
concentration of peak  dynamic loading and may provided effective pain 
relief  in patients with knee Osteo arthritis. It is  of  greatest benefit when the 
disease is only moderately advanced. Arthroscopic removal  of  loose 
cartilage fragments can prevent locking  and relieve pain. 
    Chondroplasty has also  had some popularity as treatment of Osteo 
arthritis,   but well-controlled studies of its  efficacy are  lacking , the 
fibrocartilage that resurfaces the abraded bone is inferior to normal hyaline 
cartilage in its ability to  withstand mechanical loads. In patients who had 
undergone tibial  osteotomy for medial compartment knee Osteo 
arthritis,knee pain and function were not related to the extent of cartilage 
regeneration 2 years later.    
        Autologous chondrocyte transplantation and attempts at cartilage repair 
using mesenchymal stem cells and autologous osteochondral plugs are 
currently being used experimentally for repair of focal chondral defects, but 
have not  proved to be effective in treatment of Osteo arthritis. 
 Management of Osteoarthirits  
Simple changes around the home and daily activities cause dramatic 
improvement in the symptomatology of osteoarthritis. The following are some 
of the measures: 
 
 
• Use of higher chair which require less effort to get in and get out should 
be considered 
• Changes to be made in the bathroom : 
• Use of Western toilets and avoding the Indian type 
• To fit the bath aids to facilitate easy getting in getting out of a bath. 
• To fit railings next to the toilet and bath to facilitate ease of 
movement. 
• Patients are advise to climb the stairs leading the good leg taking one stair 
at a time and to descend the stairs leading with the bad leg, again taking 
one stair at a time  
• To reduce the force acting across the injured joint patients advised to use 
a walking stick which acts as a third limb. The stick should be held in the 
hand opposite to the affected hip or knee. Initially it should be used 
around the home. The top of the stick should come up to the wrist when 
the patient stands and the tip should be provided with a firm rubber to 
avoid slipping. A walking stick, by providing a third limb through which 
forces can be transmitted, enables the reduction of force can be 
transmitted, enables the reduction of force across the injured joint from 
peak values of 5 to 1.5 times the body weight. 
• Footwear with hard soles and high heels should be avoided. 
• Cars with raised platforms and seats which facilitate easy getting in and 
getting out should be used. 
• If the patients are overweight, reduction in the weight helps to reduce the 
load on the joints. 
  
 
 
EXERCISE FOR KNEE PAIN 
 
 
 
 
 
  
 
 
• General: 
• Keep as upright as possible as this helps to put equal weight on 
both the legs. 
• Avoid sitting on a low or soft chair 
• Avoid curling up in bed. 
• To stretch the front of the thigh and hip, lie on the stomach at least 
once a day for five minutes to thirty minutes. 
• To use a walking stick when walking inside or outside the house  
• To avoid uneven and rough ground or surfaces while walking. 
• To wear comfortable footwears. 
•  Avoid squatting on the ground. 
Aims of the exercises in osteoarthritis knee 
• To increase the range of movements 
• To increase stability and shock absorption 
• To prevent deformity 
• To improve posture. 
• To reduce pain and stiffness. 
Rules of the exercises 
• Build up the exercises gradually 
• Avoid rough ground while exercising 
• To take warm baths before starting the exercises. 
 
 
• To perform the exercises 20 times each twice a day and later four 
times a day. 
Types of Exercises in osteoarthritis of knee 
Exercises lying on the Back 
• Pelvic tilt: Tighten the thigh and relax 
• Pelvic lift :Bend both the knees up, push on the feet and lift, old for a 
count of five and relax 
• Leg stretch: Push one leg along the floor as through you are trying to 
make it longer than the other. Hold for a count of five and then repeat 
with the other leg. 
• Alternate leg raising: Keeping the knees straight, lift alternate legs six 
inches from the ground  
Exercises Lying on your side, with the Painful Hip up 
• Side leg raising: Keep the top leg straight and lift it up as high as 
possible, hold for a count of five and relax. 
• Knee and hip flexion: Bend  hip and knee of the top leg forwards, 
and hold for a count of five. Then straighten the leg and stretch 
backwards as fas as it will go, hold for a count of five, then relax  
Exercises in Sitting Posture 
• Knees together, feet apart: Keep the knees together and move the feet 
apart, hold for a count of five then relax. 
• Feet together, knees apart :Keep the ankles together and move the kness 
apart, then relax  
 
 
Exercises in standing Posture 
• Standing leg swing: Hold into a table or chair with one hand, swing one 
leg forward and backward. Try to get the backwards swing as wide as 
possible.  
• Standing side leg swing: Hold on to a chair with both hands. Swing bad 
out as far as it will go and then in. The outward swing is the hardest part 
and the leg should be allowed to fall back under muscular control. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 MATERIALS AND METHODS 
 
  To study on clinical evaluation of the disease “AZHL KEEL VAYU” 
with the drug KARUNGOZHI CHOORANAM (INTERNAL) and 
VIDAMUTTI THYLAM (EXTERNAL) was carried out in Postgraduate 
Sirappu Maruthuvam, Government Siddha Medical College, Palayamkottai. 20 
patients of both male and female were selected for the studies and admitted in In 
patient ward for among 20 IP patients, 15 IP patients will be given massage and 
varmam treatment along with internal medicine and remaining 5 IP patients will 
be given massage fomentation without internal medicine. 
  Another 20 patients are treated with trial drug in the outpatient ward. 
SELECTION OF PATIENTS: 
INCLUSION CRITERIA: 
• Age – 40 – 65 Years 
• Sex -  Both male and female  
• Patients having symptoms of arthritis of both knee joints, swelling, 
stiffness, crepitation, restricted movements of both knee joints. 
• Patients who are willing to undergo radiological investigation and give 
blood for laboratory investigation. 
• Patient willing to sign the informed consent stating that  he/she will 
consciously stick to the treatment during 48 days but can opt out of the 
trial of his / her own conscious discretion. 
 
 
 
 
 
 
EXCLUSION CRITERIA: 
• Cardiac disease 
• Diabetes mellitus 
• Hypertension 
• Rheumatoid arthritis 
• Pregnancy and lactation 
• History of trauma 
• Tuberculosis 
• Use of narcotic drugs 
• Neurological disorder 
• Patients with any other serious illness. 
 
STUDY OF CLINICAL DIAGNOSIS: 
  A case sheet is prepared on the basis of siddha and modern method to 
diagnose the disease and individual case sheet is maintained for each patient. 
SIDDHA DIAGNOSTIC TOOLS: 
• Poriyal arithal 
• Pulanal arithal 
• Vinathal 
• Mukkutram 
• Ezhu udal thathugal 
• Envagai Thervu 
• Thinaigal 
• Paruva kalangal 
• Thega nilai 
 
 
 
LABORATORY INVESTIGATIONS: 
 
Blood   Urine 
TC    Albumin 
DC    Sugar 
ESR    Deposit 
Hb 
Aso  titre 
Radiological investigations: 
  X- ray of the knee joints  (AP and Lat view) Improvement assessed by 
following assessments. 
Administration of trial medicine 
  The trial drug was prepared carefully according to the siddha literature 
and given to 40 patients three times a day. 
  The Biochemical analysis was performed in Biochemical laboratory. 
• The pharmacological analysis of trial drug for its analgesic, Acute anti-
inflammatory, chronic Anti-inflammatory was performed in 
pharmacological laboratory. 
• Observation of patients with signs and symptoms of the disease and their 
prognosis were noted. 
• Patients also advised to given hot water fomentation, some exercise for 
better prognosis. 
 
 
 
ASSESSMENT OF PROGNOSIS: 
1. Clinical Assessement: 
• Pain and swelling in both knee joints 
• Stiffness in both knee joint 
• Crepitation in joint line, medial condyle 
• Tenderness in joint line, medial condyle of knee joint 
• Warmth 
• Periarticular atrophy 
• Restricted movements of  both the knee joints. 
 
2. Radiological Assessment: 
  X-ray of the both knee (AP view and lateral view) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RESULTS AND OBSERVATION 
 Results of the study were observed with respect to the following criteria. 
1. Sex Distribution 
2. Age Distribution 
3. Kaalam (Life span) 
4. Paruva Kaalam (seasonal changes) 
5. Thinai ( 5 land types) 
6. Duration of illness 
7. Occupational status 
8. Diet 
9. Onset of Disease 
10. Socio economic status 
11. Clinical features 
12. Radiological findings 
13. Disturbances in Vatham 
14. Disturbance in Pitham 
15. Disturbance in Kapham 
16. Udal thathukkal 
17. Envagai thervugal 
18. Yakkai illakanam 
19. Assessment of the Effect of therapy 
 
 
 
 
1. Age Distribution: 
S.No Age No.of  
Cases 
Percentage 
1. 41-45 4 10% 
2. 46-50 5 12.5% 
3. 51-55 4 10% 
4. 56-60 12 30% 
5. 61-65 7 17.5% 
6. 66-70 7 17.5% 
7. 71-75 1 2.5% 
 
 
 
 
 
Most of the cases were above the age group of 55.  
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2. Sex Distribution: 
S.No Among 
Sex 
No.of  
Cases 
Percentage 
1. Male 22 55% 
 
2. Female 18 45% 
.  
 
 
Among 40 cases 22(55%) were males and 18(45%) were females.  
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3. Kaalam:  
     Kaalam No.of Cases Percentage 
1. Vadham  
(upto 33 yrs to 66 yrs)  
-        - 
2. Pittham    
(33 yrs to 66 yrs) 
32     80% 
3. Kabam  
(above 66 yrs) 
8     20% 
 
  
 
 
Most of the cases 80% were in Pittha Kaalam and the rest were reported 
in Kaba Kaalam. 
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4. Paruva Kaalam: 
S.No Paruvakaalam No.of Cases Percentage 
1. Kaar (Aaavani, Purattasi)  
(Aug 16 – Oct 15) 
18 45 % 
2. Koothir (Iypasi, Karthigai)  
(Oct 16 – Dec 15) 
7 17.5% 
3. Munpani (Margali, thai)  
(Dec 16 – Feb 15) 
- - 
4. Pinpani (Masi, Pankuni)  
(Feb 16 – April15) 
- - 
5. Elavenil (Chithirai, Vaikasi) 
(Apr 16 – June 15) 
- - 
6. Muthuvenil (Aani, Aadi)  
(June 16 – Aug 15) 
15 37.5% 
 
 
The maximum incidence of Azhal Keelvayu was during the Kaar 
Kaalam,Muthuvenil Kaalam and  Koothir Kaalam.  
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5. Thinai (Place): 
S.No Thinai No.of Cases Percentage 
1. Kurinji (Hill area) 2 5% 
2. Mullai (Forest area) - - 
3. Marutham (Fertile area) 30 75% 
4. Neithal (Coastal area) 8 20% 
5. Paalai (Desert area) - - 
  
 
Among the 40 cases, majority were from Marutha  Nilam(75%). 
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6. Duration of Illness: 
 
S.No Duration (Months) No.of.Cases Percentage 
1. 0-3 8 20% 
2. 3-6 5 12.5% 
3. 6-12 13 32.5% 
4. 12-24 12 30% 
5. 24-36 2 5% 
 
 
Among the 60 cases, most of them had the duration of the illness - upto 1 year.  
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7. Occupational status: 
 
 
  
 
 
 
 
 
Occupational status shows Manual labours and Ryot were more affected.  
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S.No Nature of Work No.of Cases Percentage 
1. Ryot 18 45% 
2. Manual labour 10 25% 
3. Home Makers 10 25% 
4. Teachers 2 5% 
 
 
8. Diet Reference: 
  
 
 
  
 According to this study 100% of cases were reported as Nonvegetarian. 
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S.No Diet Habit No. of Cases Percentage 
1.  Vegetarian - - 
2. Non vegetarian 40 100% 
 
 
9. Mode of Onset: 
S.No Mode of onset No. of Cases Percentage 
1. Acute - - 
2. Gradual 40 100% 
 
 According to this study 100% of cases were reported gradual onset of 
disease. 
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 10.The Socio – Economic Status: 
S.No Socio – economic status No. of Cases Percentage 
1. Poor 34 85% 
2. Middle class 4 10% 
3. Rich 2 5% 
 
 
 
According to this study 85% of the cases were poor socio – economic status, 
10% cases were from middle class families and only  
5 % from rich background.  
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11. Clinical Features of patients: 
S.No Signs and Symptoms No.of Cases Percentage 
1. Pain, tenderness 40 100% 
2. Swelling 22 55% 
3. Morning stiffness 5 12.5% 
4. Crepitations 40 100% 
5. Muscle Wasting 1 2.5% 
6. Deformity 4 10% 
7. Constipation 6 15% 
8. Loss of appetite 4 10% 
9. Limited Movements 34 85% 
 
 
Among the twenty cases all of them (100%) had pain, tenderness and 
crepitations. 5 patients (12.5%)  had morning stiffness.  15% of the patients had 
constipation and 85% had painful limited movements. 
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12. Radiological Findings in  patients 
S.No Findings No.of Cases Percentage 
1. Joint space narrowing 40 100% 
2. Inter condylar notch prominence 5 12.5% 
3. Presence of Osteophytes 22 55% 
4. Subchondral Sclerosis 20 50% 
5. Osteoporosis 5 12.5% 
6. Deformity 5 12.5% 
7. Soft tissues swelling 2 5% 
 
 
Joint Space narrowed in all cases (100%), Osteophytes present in 22 cases 
(55%). 
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13. Distubrances of Vatha: 
Table showing the derangement of vatham: 
S.No Vatham No.of Cases Percentage 
1. Pranan - - 
2. Abanan 32 80% 
3. Viyanan 40 100% 
4. Uthanan - - 
5. Samanan 40 100% 
6. Naagan - - 
7. Koorman 2 5% 
8. Kirukaran - - 
9. Devethathan  35 87.5% 
10. Dhananjeyan - - 
 
 
• Both Viyanan ans Samanan were affected in all the 40 cases (100%) 
• Abanan was affected in 32 cases (80%).  
• Devethathan was affected in 35cases (87.5%) 
• Koorman was affected in 2 cases (5%) 
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•  
14.Distubrances in Pitham: 
 
S.No Pitham  No.of Cases Percentage 
1. Analapitham 10 25% 
2. Ranjagam 6 15% 
3. Saathagam 40 100 % 
4. Prasagam - - 
5. Alosagam - - 
 
Saathaga Pitham was affected in all 40 cases (100%) 
Analapitham was affected in 10 cases (25%) 
Ranjagam was affected in 6 cases (15%)  
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15. Table showing the derangement of Kapham: 
S.No Kapham No.of Cases Percentage 
1. Avalambagam - - 
2. Kilethagam 10 25% 
3. Pothagam - - 
4. Tharpagam - - 
5. Santhigam 40 100% 
  
 
In all the 60 cases (100%) Santhigam was affected.Kilethagam was affected in 6 
cases (10%) 
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16.Table Showing the condition of Udal Kattugal: 
S.No Udal Kattugal No.of Cases Percentage 
1. Saaram 40 100% 
2. Senneer 6 15% 
3. Oon 2 5% 
4. Kozhuppu 40 100% 
5. Enbu 40 100% 
6. Moolai 40 100% 
7. Venneer/Suronitham - - 
 In all the cases Saaram, Kozhuppu, Enbu and Moolai were affected 
(100%),Senneer was affected in 6cases (15%) and Oon was affected in 2 cases 
(5%)
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17.Ennvagai Thervugal: 
S.No Ennvagai thervugal No. of Cases Percentage 
1. Sparisam 40 100% 
2. Naa 10 25% 
3. Niram 10 25% 
4. Mozhi - - 
5. Vizhi 2 5% 
6. Malam 32 80% 
7. Moothiram 2 5% 
8. Naadi 40 100% 
 
 
Naadi  - Pitha Vatham 13 cases (32.5%) 
Vatha Pitham 25 cases (62.5%) 
    Pitham Kapham 2 cases (5%) 
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18.Yakkai Ilakkanam (Physical Constitutions) 
S.No Yakkai Ilakkanam No.of Cases Percentage 
1. Vatha udal 2 5% 
2. Pitha udal - - 
3. Kapha udal 6 15% 
4. Thontha udal 32 80% 
Out of 40 cases were of Thontha udal.  Out 32 cases, 16 pitha vatha udal 
and 16 vatha pitha udal. 
19. Assessment of Effect of Theraphy: 
Marked Effect: 
 No longer any clinical manifestations 
 Patient could work and live normally 
 No recurrence after some months. 
Moderate Effect: 
 Moderate reduction of manifestations. 
 Slight pain after movement 
Mild Effect: 
 Slight reduction in the clinical manifestation  
 With relapse 
 
 
 
 
 
 
 
 
Effect of therapy No.of Cases Percentage 
Marked 25 62.5% 
Moderate 10 25% 
Mild 5 12.5% 
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Joint line tenderness (Knee) in Inpatients: 
S.No Patient Name Age/Sex Ip.No 
Before 
Treatment in 
Grades 
After 
Treatment in 
Grades 
1. Subbiah 70/M 2268 III I 
2. Sudaliammal 60/F 2269 III           I 
3. Lakshmi 75/F 2337 II Nil 
4. Veerammal 65/F 2569 II I 
5. Gandhimathi 58/F 2723 III I 
6. Vadivel 70/M 2933 II I 
7. Nainar 70/M 3060 II I 
8. Muthusamy 58/M 3082 II Nil 
9. Nambi 69/M 3108 III II 
10. Nalla thai 65/F 3113 III I 
11. Arumugam 56/M 3132 III I 
12. Gomu 60/F 3187 II I 
13. Muniyandi 68/M 3204 II Nil 
14. Shanmugathai 69/F 3362 II Nil 
15. Peter 54/M 3367 II I 
16. Paul nadar 65/M 3372 II I 
17. Saraswathy 60/F 3940 III I 
18. Petchiammal 70/F 4352 III I 
19. Michelammal 58/F 4361 III II 
20. Subbiah 65/M 4441 II I 
 
 
 
 
 
Assessment of joint tenderness 
Grade I : The patient says the joint is tender 
Grade II : The patient winces 
Grade III : The patient winces and withdraws the affected part 
Grade IV : The patient will not allow the joint to be touched.  
Joint line  tenderness (Knee) in Outpatients: 
S.No Patient Name Age/Sex Ip.No 
Before 
Treatment in 
Grades 
After 
Treatment in 
Grades 
1. Vadivel 62/M 52172 III I 
2. Raja 45/M 52490 II         Nil 
3. Santha 60/F 52539 III II 
4. Velammal 42/F 56218 II Nil 
5. Santhi 47/F 56576 III Nil 
6. Suresh 40/M 56918 II I 
7. Shanmugavel 65/M 57259 III I 
8. Kannan 60/M 58001 II I 
9. Nainar 60/M 58893 III I 
10. Petchiammal 50/F 60777 II Nil 
11. Muthulakshmi 40/F 61417 II Nil 
12. Lakshmi 60/F 62802 III I 
13. Subbulakshmi 57/F 65413 III I 
14. Petchiammal 53/F 67171 III I 
15. Saraswathy 50/F 72049 II Nil 
16. Saraswathy 50/F 74170 III II 
 
 
17. Thavasi Nadar 70/M 76277 III I 
18. Arumugam 55/M 79076 II I 
19. Madasamy 65/M 94113 III I 
20. Ayishabeevi 47/F 94118 III I 
 
Assessment of joint tenderness 
Grade I : The patient says the joint is tender 
Grade II : The patient winces 
Grade III : The patient winces and withdraws the affected part 
Grade IV : The patient will not allow the joint to be touched. 
  
 
 
SUBBIAH, Age 60, Male 
 
 
Nambi, Age 70, Male 
 
  
 
 
  
ASSESSMENT OF SWELLING IN INPATIENT 
 
S.
N
O 
 
 
I.P.
NO 
 
 
 
NAME 
 
A
GE 
/S
EX 
BEFORE TREATMENT AFTER   TREATMENT 
RT(CM) LT(CM) RT(CM) LT(CM) 
Up
per 
Mid
dle 
lo
we
r 
up
per 
mid
dle 
lo
we
r 
Up
per 
mid
dle 
lo
we
r 
up
per 
Mid
dle 
Lo
wer 
  1 226
9 
Sudali 
ammal 
60/
F 
32 34.5 35 31 34 35.5 31 34 34.5 30.5 33 35 
      
2 
256
9 
Veer 
ammal 
65/
F 
34 35.5 35 33.5 34.5 34 33.5 35 34.5 33.5 35 33.
5 
       
3 
293
3 
Vadive
l 
70/
M 
34.5 35 35.5 35 36 35.5 34 34.5 35 35 35.5 35 
      
4 
306
0 
Nainaa
r 
70/
M 
35 34 36 35.5 35 35.5 34.5 33 35.5 35 34.5 35 
      
5 
310
8 
Nambi 69/
M 
36 34 35 35 33.5 34 36 34 55 33.5 34 36 
      
6 
320
4 
Muiya
ndi 
68/
M 
37 35 36 35 34 35.5 36 34 35 35 33.5 35 
      
7 
336
7 
Peter 54/
M 
35 34.5 35 34 33.5 33 34.5 34 34 34 33.5 33 
      
8 
311
3 
Nalla 
thai 
65/
F 
36 35 34.5 35 34.5 34 35.5 34 33.5 35 34.5 34 
       
9 
313
2 
Arumu
gam 
56/
F 
36 35 34 38 35.5 36 36 35 34 36 35 34.
5 
    
10 
318
7 
Gomu 60/
F 
35 34 33.5 36 34 35.5 35 34 33.5 35 33.5 35 
11 394
0 
Sarasw
athi 
60/
F 
36 35 34.5 35 34.5 34 35.5 34 34 35 34.5 34 
12 436
1 
Mikkel 
ammal 
58/
F 
35 34.5 33 35.5 34 35 34.5 34 33 35 33.5 34.
5 
 
 
 
 
 
Among 20 cases : 
 Marked Effect  -  8 cases 
 Moderate   - 10 cases 
 Mild   - 2 cases  
LIST OF OUT PATIENT IN SWELLING 
S.
N
O 
O.P NO NAME AGE/
SEX 
          Before  treatment               After  treatment 
                 RT       LT             RT           LT 
1 52537 Shratha 60/F 37 35 36 35 34 33 35 34.5 35 35 34 33 
2 57259 Shanmuga 
vel 
65/M 36 35 34.5 35 34 33.5 35.5 34.5 34 34 33.5 33 
3 58893 Nainaar 60/M 35 34.5 33.5 36 35 34 35 34.5 33.5 35 34 33 
4 72049 Saraswathi 50/F 33.
5 
33 33.5 35 34.5 35 33.5 33 33.5 34 33.5 34 
5 94113 MadasamY 65/M 35 34 33.5 34.5 33 34.5 34.5 33 34 34 33 34 
6 94118 Ayisha beevi 47/F 36 35 35.5 37 35.5 35 35.5 34.5 35 36.5 35 34.5 
7 61417 Muthu 
lakshmi 
40/F 35 33.5 34 35 33.5 34 34 33 33.5 35 33.5 34 
8 65413 Subbu lakshmi 57/F 36 35 34.5 35 34 33.5 35.5 34 34.5 34.5 33.5 33 
 
 
OP CASES - CLINICAL IMPROVEMENT 
Sl. 
No 
OP 
NO NAME AGE SEX DOA DOD 
TREA
TED 
DAYS 
RESULT 
1 52172 Vadivel 62 M 20.07.12 01.09.12 42 Marked 
2 52490 Raja 45 M 25.07.12 08.09.12 43 Marked 
3 52539 Shantha 60 F 03.08.2 17.09.12 55 Moderate 
4 56218 Velammal 42 F 08.08.12 18.10.12 40 Marked 
5 56576 Shanthi 47 F 16.08.12 20.10.12 66 Moderate 
6 56918 Suresh 40 M 17.08.12 17.10.12 60 Marked 
7 57259 Shanmugavel 65 M 21.08.12 10.01.13 109 Marked 
8 58001 Kannan 60 M 09.08.12 09.10.12 60 Moderate 
9 58893 Nainaar 60 M 03.08.12 07.11.12 64 Marked 
10 60777 Petchiammal 50 F 10.08.12 06.10.12 57 Marked 
11 61417 Muthulakshmi 40 F 23.08.12 25.10.12 63 Marked 
12 62802 Lakshmi 60 F 25.08.12 12.10.12 47 Moderate 
13 65413 Subbulakshmi 57 F 28.08.12 30.12.12 63 Marked 
14 67171 Petchiammal 53 F 01.09.12 30.11.12 90 Marked 
15 72049 Saraswathi 50 F 05.09.12 28.12.12 83 Moderate 
16 74170 Saraswathi 50 F 06.09.12 10.12.12 64 Marked 
17 76777 Thavasi Nadar 70 M 11.09.12 01.01.13 53 Moderate 
18 79076 Arumugam 55 M 12.09.12 10.01.13 60 Marked 
19 94113 Madasamy 65 M 26.10.12 12.01.13 77 Marked 
20 94118 Ayisha Beevi 47 F 14.09.12 20.10.12 36 Moderate 
 
 
 
IP CASES - CLINICAL IMPROVEMENT 
Sl. 
No 
IP 
NO 
NAME AGE SEX DOA DOD 
TREA
TED 
DAYS 
RESULT 
1 2268 Subbaiah 70 M 23.07.12 22.09.12 62 Moderate 
2 2269 Sudaliammal 60 F 23.07.12 29.08.12 35 Mild 
3 2337 Lakshmi 75 F 25.07.12 26.08.12 33 Marked 
4 2569 Veerammal 65 F 28.07.12 01.09.12 36 Marked 
5 2728 Kanthimathi 50 F 10.08.12 15.09.12 36 Marked 
6 2933 Vadivel 70 M 15.08.12 22.09.12 38 Moderate 
7 3060 Nainaar 70 M 18.08.12 30.09.12 43 Moderate 
8 3082 Muthusamy 50 M 20.08.12 10.09.12 21 Marked 
9 3108 Nambi 69 M 26.08.12 10.10.12 45 Mild 
10 3113 Nallathai 65 M 01.09.12 15.10.12 45 Marked 
11 3132 Arumugam 56 F 03.09.12 13.10.12 40 Marked 
12 3187 Gomu 68 F 10.09.12 11.10.12 31 Marked 
13 3204 Muniyandi 68 M 10.09.12 10.10.12 30 Marked 
14 3362 Shanmugathai 69 F 20.09.12 25.10.12 35 Marked 
15 3367 Peter 54 M 25.09.12 10.10.12 16 Moderate 
16 3372 Paulnadar 65 M 26.09.12 19.10.12 25 Moderate 
17 3940 Saraswathi 60 F 20.11.12 02.01.13 43 Mild 
18 4352 Petchiammal 70 F 20.11.12 10.12.12 20 Moderate 
19 4361 Mickalammal 58 F 26.11.12 12.12.12 17 Moderate 
20 4441 Subbaiah 65 M 02.01.13 13.01.13 12 Mild 
 
 
SELECTION OF PATIENTS: 
 
TREATMENT  OPTIONS 
NO OF 
PATIENTS 
Trial drugs only (Int & Ext medicine) 25 
Trial drugs +External therapies 
      (Int & Ext medicine) 
10 
External therapy only 5 
 
 
Inference:     
This Clinical study includes 40 Patients, i.e. 20 from IP ward and 20 Patients from 
OP ward. 10 OP patients were given both Internal and External medicines, 15 IP cases 
were given Internal, External medicine alongwith external theraphy 5 IP cases, were 
given only External theraphy. 
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EFFECT OF TRIAL DRUG ALONE: 
Effect of therapy is assessed from the above tabulated data. 
Effect of the Therapy No. of Patients Percentage 
Good 7 28 
Moderate 14 56 
Mild 4 16 
NIL 0 0 
 
Inference: 
         By treating alone with trial drugs, 28 % of patients had good improvement, 
 56 % of patients had moderate improvement, 16% had mild improvement,  
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EFFECT OF TRIAL DRUG ALONG WITH  COMPLEMENTARY THERAPIES: 
EFFECT OF THERAPY NO. OF PATIENTS PERCENTAGE 
Good 4 40 
Moderate 5 50 
Mild 1 10 
No 0 0 
 
 
Inference: 
         By treating both with trial drugs and external therapies, 40 % of patients had good 
improvement, 50% of patients had moderate improvement and 10 % only had mild 
improvement.  
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EFFECT OF COMPLEMENTARY THERAPY ALONE: 
 
EFFECT OF THERAPY NO. OF PATIENTS PERCENTAGE 
Good 1 20 
Moderate 2 40 
Mild 2 40 
Nil 0 0 
 
Inference: 
                      By treating external therapies only, 20% of patients had good improvement, 
40% of patients had moderate improvement and 40 % only had mild improvement.  
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List of In Patients of PG III – Sirappu Maruthuvum Department – Blood Analysis Karungozhi Chooranam as 
internal medicine and Vidamutti Thylam as external medicine 
S 
.No 
IP 
.No Name 
Age 
/Sex 
TC 
Cells/Cumm DC Cells/Cumm Hb mgs ESR mm/hr 
Sugar 
(mgs) 
Urea 
(mgs) 
Cholesterol 
(mgs) 
BT AT 
BT AT 
BT AT 
BT AT 
BT AT BT AT BT AT P L E P L E ½ hr 1hr 
½ 
hr 1hr 
1 2268 Subbaiah 70 M 8700 8900 56 41 3 55 43 2 11.2 11.4 22 44 10 20 76 78 22 20 124 124 
2 2269 Sudaliammal 60 F 8900 9000 56 41 3 52 46 2 10.8 11 45 93 20 40 82 80 24 22 155 155 
3 2337 Lakshmi 75 F 8700 8900 49 48 3 56 39 5 9 10 12 23 8 16 110 108 22 18 211 200 
4 2569 Veerammal 65 F 8400 8600 56 39 5 56 41 3 11.5 11.8 24 56 12 24 112 110 29 24 178 175 
5 2723 Kanthimathi 50 F 7500 7800 67 28 5 67 32 1 9.8 10 23 48 6 12 216 200 32 28 150 150 
6 2933 Vadivel 70 M 7500 7800 60 36 4 60 38 2 11 11 16 11 3 6 79 75 33 30 177 175 
7 3060 Nainaar 70 M 8200 8500 54 32 4 56 32 2 9 10 12 24 6 12 83 80 23 22 158 150 
8 3082 Muthusamy 50 M 7000 7200 58 38 4 58 40 2 7 9 22 44 10 2 80 80 20 20 180 180 
9 3108 Nambi 69 M 9800 9800 60 28 12 60 38 2 11 11.2 10 20 5 10 113 113 22 22 167 160 
10 3113 Nallathai 65 M 8900 8700 67 30 3 65 32 3 9 10 23 48 10 20 79 79 23 23 177 177 
11 3132 Arumugam 56 F 8000 8200 62 36 2 68 30 2 9.2 9.4 12 24 10 20 84 84 22 22 156 150 
12 3187 Gomu 60 F 8200 8400 58 38 4 60 38 2 10 10 10 20 6 12 112 100 23 23 167 160 
13 3204 Muniyandi 68 M 8400 8600 66 30 4 62 36 2 12.5 12.5 30 60 15 30 92 90 39 32 177 170 
14 3362 Shanmugathai 69 F 7200 7400 68 34 4 65 34 1 9 9.2 12 24 12 24 80 80 30 20 175 170 
15 3367 Peter 54 M  9000 9200 60 35 5 62 35 3 12.2 12 33 66 8 16 124 110 23 20 292 290 
16 3372 PaulNadar 65 M 7900 7500 63 33 4 60 36 4 11.8 12 33 66 10 20 124 126 18 20 177 150 
17 3940 Saraswathi 60 F 8100 8000 54 42 4 56 40 2 9 10 12 24 12 24 102 100 22 22 150 128 
18 4352 Petchiammal 70 F 7200 7400 58 38 4 60 38 2 10.2 10.4 22 44 10 20 112 114 24 26 128 130 
19 4361 Mickelammal 58 F  8000 8200 67 28 5 65 32 2 11 11 11 22 8 16 108 105 26 20 155 120 
20 4441 Subbaiah 65 M 8700 8800 69 30 12 62 36 2 12.4 12 15 30 6 12 180 126 20 24 220 200 
 
  
 
 
List of In Patients of PG III – Sirappu Maruthuvum Department – Blood Analysis Karungozhi Chooranam as 
internal medicine and Vidamuttithylam as external medicine 
S. 
No 
IP. 
No Name 
Age 
/Sex 
TC Cells 
/Cumm DC Cells/Cumm Hb gms% ESR mm/hr 
Sugar 
(gms%) 
Urea 
(gms%) 
Cholesterol 
(gms%) 
BT AT 
BT AT 
BT AT 
BT AT 
BT AT BT AT BT AT P L E P L E ½ hr 1hr 
½ 
hr 1hr 
1 52172 Vadivel 62/M 8900 8700 59 38 3 65 33 2 10 10.2 13 25 10 20 74 78 22 20 162 160 
2. 52490 Raja 45/M 7900 7700 56 39 5 59 39 2 13.5 13.5 2 5 2 5 76 78 20 18 193 150 
3. 52539 Shantha 60/F 8200 8000 62 35 3 59 38 3 10.2 10.4 40 88 10 20 73 74 22 20 270 200 
4. 56218 Velammal 42/F 8100 8000 63 34 3 62 38 0 12 12 12 24 6 12 80 80 18 18 128 120 
5. 56576 Shanthi 47/F 8100 8200 62 36 4 62 36 2 12 12 10 20 5 10 78 78 22 20 169 150 
6. 56918 Suresh 40/M 9200 9000 69 29 2 62 34 4 14.5 14.5 3 6 3 6 98 90 20 20 213 200 
7. 57259 Shanmugavel 65/M 8300 8300 54 33 13 69 29 2 12 12 10 20 5 10 79 76 18 18 156 150 
8. 58001 Kannan 60/M 8100 8200 62 36 2 62 36 2 12 12 10 20 6 12 82 80 22 20 181 180 
9. 5893 Nainaar 60/M 8700 8500 59 37 4 60 38 2 13 13 9 21 3 6 78 78 18 18 168 150 
10. 60777 Petchiammal 50/F 8500 8700 65 33 2 68 30 2 10.5 11 4 9 2 4 108 80 20 20 150 138 
11 61417 Muthulakshmi 40/F 8100 800 62 36 2 59 37 4 12 122 10 20 10 20 78 78 22 20 150 150 
12. 62802 Lakshmi 60/F 8700 8700 59 37 4 49 48 3 10 10.2 30 60 15 30 83 83 16 18 162 162 
13. 65413 Subbulakshmi 57/F 7000 7200 49 48 3 62 36 2 10.5 10.5 20 24 6 12 90 92 15 16 168 168 
14. 67171 Petchiammal 53/F 7500 7700 54 43 3 60 38 2 12 12 10 21 5 10 112 108 25 24 182 182 
15. 72049 Saraswathi 50/F 8100 8100 60 38 2 59 38 3 10 10.4 24 50 6 12 82 80 20 20 179 170 
16. 71470 Saraswathi 50/F 8400 8400 59 38 3 62 38 0 9.8 10 25 55 8 16 89 86 18 16 179 170 
17. 76277 Thavasi Nadar 70/M 8100 8000 62 38 0 60 38 2 10.5 10.5 20 40 10 20 92 90 18 16 186 180 
18. 79076 Arumugam 55/M 7500 700 54 43 3 49 48 3 12 12 10 21 10 20 112 112 25 22 182 180 
19. 94113 Madasamy 65/M 8400 8600 58 39 3 58 39 3 12.2 12.4 4 44 4 8 192 198 29 24 181 180 
20. 94118 Ayisha Beevi 47/F 8300 8400 68 30 2 68 32 0 11.2 11 13 25 10 20 171 170 31 26 223 220 
 
 
 
 
 
 
 
List of In Patinets of PG III – Sirappu Maruthuvam Department – Urine and Motion Analysis Karungozhi 
Chooranam as internal medicine and vidamutti thylam as external medicine 
S.No I.P.No Name Age/Sex 
Urine Analysis Motion Analysis 
BT AT BT AT 
Alb Sugar Dep Alb Sugar Dep Ova Cyst Ocualt blood Ova Cyst 
Ocualt 
blood 
1 2268 Subbaiah 70 M Nil Nil 2-5pus Nil Nil 2-3 pus Nil Nil Nil Nil Nil Nil 
2 2269 Sudaliammal 60 F Nil Nil 2-3 pus Nil Nil 2-3 pus Nil Nil Nil Nil Nil Nil 
3 2337 Lakshmi 75 F Nil Nil 1-2 pus Nil Nil 1-2 pus Nil Nil Nil Nil Nil Nil 
4 2569 Veerammal 65 F Nil Nil 1-2 epith Nil Nil 1-2 epith Nil Nil Nil Nil Nil Nil 
5 2723 Kanthimathi 50 F Nil Nil 1-2 pus Nil Nil 1-2 pus Nil Nil Nil Nil Nil Nil 
6 2933 Vadivel 70 M Nil Nil 1-5 pus  Nil Nil 1-5 pus  Nil Nil Nil Nil Nil Nil 
7 3060 Nainaar 70 M Nil Nil 1-2 epi Nil Nil 1-2 epi Nil Nil Nil Nil Nil Nil 
8 3082 Muthusamy 50 M Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil Nil Nil 
9 3108 Nambi 69 M Nil Nil 1-2 pus Nil Nil 1-2 pus Nil Nil Nil Nil Nil Nil 
10 3113 Nallathai 65 M Nil Nil 1-2 pus Nil Nil 1-2 pus Nil Nil Nil Nil Nil Nil 
11 3132 Arumugam 56 F Nil Nil 1-3 pus Nil Nil 1-3 pus Nil Nil Nil Nil Nil Nil 
12 3187 Gomu 60 F Nil Nil Few PW Nil Nil Few PW Nil Nil Nil Nil Nil Nil 
13 3204 Muniyandi 68 M Nil Nil 1-2 pus Nil Nil 1-2 pus Nil Nil Nil Nil Nil Nil 
14 3362 Shanmugathai 69 F Nil Nil 1-2 pus Nil Nil 1-2 pus Nil Nil Nil Nil Nil Nil 
15 3367 Peter 54 M  Nil Nil 1-2 epithyl Nil Nil 1-2 epithyl Nil Nil Nil Nil Nil Nil 
16 3372 PaulNadar 65 M Nil Nil 1-3 pus Nil Nil 1-3 pus Nil Nil Nil Nil Nil Nil 
17 3940 Saraswathi 60 F Nil Nil 1-2 pus Nil Nil 1-2 pus Nil Nil Nil Nil Nil Nil 
18 4352 Petchiammal 70 F Nil Nil 1-2 epi Nil Nil 1-2 epi Nil Nil Nil Nil Nil Nil 
19 4361 Mickelammal 58 F  Nil Nil 1-2 pus Nil Nil 1-2 pus Nil Nil Nil Nil Nil Nil 
20 4441 Subbaiah 65 M Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil Nil Nil 
 
  
 
 
List of In Patinets of PG III – Sirappu Maruthuvam Department – Urine and Motion Analysis Karungozhi 
Chooranam as internal medicine and vidamutti thylam as external medicine 
S.No I.P.No Name Age/Sex 
Urine Analysis Motion Analysis 
BT AT BT AT 
Alb Sugar Dep Alb Sugar Dep Ova Cyst Ocualt blood Ova Cyst 
Ocualt 
blood 
1 52172 Vadivel 62/M Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil Nil Nil 
2 52490 Raja 45/M Nil Nil 8-10 pus 1-2 epi Nil Nil 1-2 epi Nil Nil Nil Nil Nil Nil 
3 52539 Shantha 60/F Nil Nil Fewpus epi cells Nil Nil 
Fewpus epi 
cells Nil Nil Nil Nil Nil Nil 
4 56218 Velammal 42/F Nil Nil 2-4 pus cells Nil Nil 1-2 pus cells Nil Nil Nil Nil Nil Nil 
5 56576 Shanthi 47/F Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil Nil Nil 
6 56918 Suresh 40/M Nil Nil 1-3 pus cells Nil Nil 1-3 pus cells Nil Nil Nil Nil Nil Nil 
7 57259 Shanmugavel 65/M Nil Nil Few Puscells Nil Nil Few Puscells Nil Nil Nil Nil Nil Nil 
8 58001 Kannan 60/M Nil Nil Fewpus Nil Nil Fewpus Nil Nil Nil Nil Nil Nil 
9 5893 Nainaar 60/M Nil Nil Fewpus Nil Nil Fewpus Nil Nil Nil Nil Nil Nil 
10 60777 Petchiammal 50/F Nil Nil 1-2 epi Nil Nil 1-2 epi Nil Nil Nil Nil Nil Nil 
11 61417 Muthulakshmi 40/F Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil Nil Nil 
12 62802 Lakshmi 60/F Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil Nil Nil 
13 65413 Subbulakshmi 57/F Nil Nil 1-2 epi cells Nil Nil 1-2 epi cells Nil Nil Nil Nil Nil Nil 
14 67171 Petchiammal 53/F Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil Nil Nil 
15 72049 Saraswathi 50/F Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil Nil Nil 
16 71470 Saraswathi 50/F Nil Nil 1-2 pus Nil Nil 1-2 pus Nil Nil Nil Nil Nil Nil 
17 76277 Thavasi Nadar 70/M Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil Nil Nil 
18 79076 Arumugam 55/M Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil Nil Nil 
19 94113 Madasamy 65/M Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil Nil Nil 
20 94118 Ayisha Beevi 47/F Nil Nil 2-3 epi Nil Nil 2-3 epi Nil Nil Nil Nil Nil Nil 
 
 
 
  
 
 
DISCUSSION 
Azhal Keel Vayu is one of the major  joint problems i.e, really the 
weight bearing joints affected which makes the elder people most troublesome 
especially. The disease Azhal keel vayu as explained in siddha system of 
medicine has got close resemblance with that of osteoarthritis of modern system 
of medicine.  
The drug to treat this disease were Karungozhi Chooranam- Internally 
and Vidamutty thylam Externally. This study is trial to throw light the role of 
the drugs in all aspects in the management of the disease.   
Fourty  cases of Azhal keel vayu were diagnosed clinically on the basis 
of sings and symptoms described in the text Siddha maruthuvam. The clinical 
diagnosis was made confirmed by means of other  siddha aspects of 
examinations out of  20 cases in the out patients ward and 20 cases in the 
inpatients ward – in the DEPARTMENT OF PG SIRAPPU 
MARUTHUVAM.  
Age distribution: 
According to this study, most of the patients were above the age of 55 
which was already explained by modern science that degeneration due to aging 
is important cause for osteoarthritis. 
Sex Distribution: 
Among the Fourty cases,22(55%)were male and 18(45%)were female 
patients. 
Prevalence of affecting the joints: 
In Azhal Keel Vayu the hallmark of involvements are articular joints, 
perdominantly Knee Joint (100%). 
 
Duration of the illness: 
According to this study the duration of the illness varies fom  1month to 
1yr. 
 
 
Socio – economic status: 
Among the 40cases selected for this study 34cases (85%)were poor 
class,4cases10% middle class and  only 2cases(5%)were from rich background. 
Occupational  status 
Occupational place the important role in the aetiology of Azhal Keel 
Vayu. Ryot for 15cases(40%)Manual labour account for 12(30%) cases.Home 
makers 10cases(25%) and 5% of teachers  were also affected by the disease.The 
main cause of this disease is  repeated use of  joints.  
Clinical Manifestation: 
The major clinical symptom reported to be pain in the joints and 
tenderness along joint line and crepitation (100%) in the knee joints followed by  
85% had limited movement of the joints,15% of them had constipation 10% of 
them had morning stiffness  and  55% had swelling in knee joint. 
Paruva Kaalam: 
Kaar Kaalam, Koothir Kaalam and Muthuvenil Kaalam a as 45%, 37.5%, 
and 17.5% shows their incidence. 
Thinai: 
The incidence of Azhal Keelvayu is high in people from Martutha Nilam 
(70%), Neithal Nilam (20%) and Kurinchi Nilam (5%). 
Generally in marutha nilam, all the three doshas are in physiological 
ratio, but for these 40 patients the occupation, age and Pollution alter the 
physiological ratio and cause the disease. 
Diet: 
I have selected all cases are 100% Non-vegetarian because my trial drug 
is Karungozhi chooranam.  
Almost all the patients were found of eating high calorific food like junk 
foods, deep fried items which results in over weight. Out of 40 patients, 6cases 
were overweight . 
 
 
 
Disturbance in Vatham: 
In the fourty cases,  in all of them (100%) Viyanan and Samanan were 
affected. Devathathan was affected in 35 cases (87.5%).Abanan was affected in 
32 (80%) cases.  Koorman was affected in  2 (5%). 
Disturbance in Pittham: 
According to this study, Sathagapitham was affected in all 40 cases 100% 
Analapitham in 10 cases (25%) and Ranjagapitham in 6 (15%) cases. 
Disturbance in Kabam: 
According to this study santhigam was affected in all the cases 
(100%).Kilethagam was affected in 10 (25%) cases. 
Udal Kattugal: 
Among the Seven Udal Kattugal, Saaram, Kozhuppu, Enbu and Moolai 
were affected in 40 (100%) cases. Senneer were affected in 6(15%). 
Derangement in eight parameters in our systems (Envagi thervugal): 
According to this study, in Ennvagai thervugal, Naadi was affected in all 
the cases (100%), Malam was affected in 32 cases(80%).Naa and Niram were  
affected in 10 cases (25%) Sparism was affected in (100%) 40 cases. Vizhi was 
affected in 2 cases (5%). 
Laboratory investigation: 
• Blood (TC, DC, ESR, Hb %, Sugar, Urea, Cholestrol)  
• Urine (albumin, Sugar, deposits) were done for all 60 cases.   
• Anaemia was found in 6 cases (15%) There was not much remarkable 
changes in the TCand DC. 
Effect of therapy: 
On the basis of assessment of the curative effect of the trial drugs,  
• Marked effect was recorded in 60% of cases. 
• Moderate effect was observed in 30% of cases  
• Mild effect was observed in  10%.   
 
 
The trial drugs showed improvement in prognosis of the disease clinically 
rather than radiographically. 
Biochemical Analysis: 
Bio Chemical analysis of the trial drug was done in the Department of 
Bio-Chemistry, Government Siddha Medical College, Palayamkottai. 
Karungozhi Chooranam ;contains. 
• Calcium 
• Sulphate 
• Phosphate  
• Ferrous iron  
• Chloride 
• Aminoacid 
• Unsaturated compound 
All these Bio-Chemical products are much important for bone growth and 
its maintenance. 
No toxic or side effects were clinically observed in any cases. 
Pharmacological Analysis 
Pharmacological studies done in Pharmacology Department of 
Government Siddha Medical College, Palayamkottai.  The results were reported 
as follows. 
Internal Medicine: 
Karungozhi Chooranam 
• Significant Analgesic action  
• Significant Acute Anti –inflammatory action 
• Significant Chronic Anti – inflammatory action 
External Medicine: 
Vidamutty thylam has significant Analgesic action and significant Acute Anti 
inflammatory action. 
 
 
 
SUMMARY 
Fourty cases of   Azhal Keel Vayu, was  clinically diagnosed initially. 
Out of them twenty   cases were admitted in the in-patient PG Sirappu 
Maurthuvam Ward, Govt. Siddha Medical College Hospital, Palayamkottai 
were observed for clinical diagnosis, lab diagnosis and treatment by the trial 
medicines. .  Among  them  twenty cases treated in  out patients ward in PG 
Sirappu Maruthuvam. 
• Clinical diagnosis of Azhal keel vayu was done on the basis of clinical 
features described in Sabapathi Manuscript, and siddha maruthuvam text. 
• Before starting the treatment, careful detailed history was taken out and 
recorded for the 60 selected cases only. 
• The various Siddha aspects of examination of the disease were carried out 
and data were recorded in the proforma. 
• Laboratory diagnosis of Azhal Keel Vayu was done by modern methods of 
examination in the Govt.  Siddha Medical College Hospital, Palayamkottai. 
Confirm the diagnosis in siddha syestem with the help of   modern parameter                                                                                                  
given to all  cases . 
• The trial medicine choosen for both internal and external treatment and the 
management of Azhal Keelvayu. 
• Karungozhi Chooranam normal dose 500mg  thrice a day with  hot 
water.   
• Vidamutti Thylam(Externally).  
• The observation  made during the clinical study shows that the main drug 
Guggulu chooranam (Internally) is clinically effective. It has significant 
Analgesic action and Significant of Acute and Chronic  Anti 
Inflammatory Action. 
• The action of  Vidamutti thylam (Externally) over the affected joint was 
also clinically effective.  It has Significant Analgesic action and  
Significant Acute - Anti Inflammatory Action. 
 
 
• Biochemical analysis of Karungozhi chooranam contains 
calcium,sulphate,chloride,ferrous iron,phosphate,unsaturated compound and 
amino acid which are most important for bone growth.   
• Efficacy of  complementary  therapies   are  analysed  
• The drugs were found to be free from adverse effects. 
 
  
 
 
CONCLUSION 
Vadha diseases dealt by many of the siddhars like Yugi, Agathiyar, 
Sarabenthirar etc… Azhal keel vaayu described in sabapathy kaiyedu below the 
topic of keel vaayu. 
   Keel vaayu is most common problem in elderly people.   in   siddha 
literature said that the major problem of “Narai, Thirai, Moopu”. In moopu there 
are many problems will be arised. Degenarative changes of joints occur in this 
stage, Deformity also occur. 
 For this reason I have chosen this disease for my dissertation. I 
have selected medicine “Karungozhi Chooranam” from of “Agathiyar 2000”. 
Indication of this trial drug for vadha disease such as muttu vali, Udhira vadha 
suronitham. Ingredient of trial drug contains anti vadha properties. This trial 
drug undergone for the pharmacological study which shows analgesic and anti 
inflammatory peoperties . Fourty patients selected for this study were treated 
with  Karungozhi Chooranam (Internally)  500 mg thrice a day with hot 
water  and  Vida mutti thylam (Externally). 
 Clinical result shows improvement as following, 
 Marked effect in 25 cases  - 62.5% 
 Moderate effect in 10 cases  - 25% 
 Mild effect in 5 cases   - 12.5   %    
 It was noted that the internal drug  Karungozhi Choornam was free 
from adverse side effects i.e. no cases were reported either nausea, vomiting, 
gastric irritation, other GI disturbance and allergic manifestations. 
External application  Vida mutti thylam  was not irritant i.e no cases were 
reported itching or eruption whenever applied.  
  
 
 
ANNEXURE I 
 PROPERTIES OF THE TRIAL DRUG  
INTERNAL MEDICINE – KARUNGOZHI CHOORANAM 
 “Nfhopf; fhypwF jiyAk; Nghf;fp fjpf;fKJ fJ  
     gpse;JFly; thq;fp Nghl;Lj; 
 fhh;Ngh fhprpfUQ; rPufk; ew;rPufQ; rhjpf;fha; 
     rhjpg;gj; jphpapNdyk; 
 ngUq;fhaQ; Rf;fpDld; kpsF jpg;gpyp Nahkk; Nguhd 
     ytq;fg;gl;il trk;Gs;sp 
 fhj Nguuj;ij Gd;KUq;if Nth;nrq;fj; jhhpj;Njh. 
     rq;FkapybNth; FUe;jd; NtNu 
 NtW rhpepd;w ajpd;ghjp gwq;fpg;gl;il 
     kpfj;J}s; gz;zp 
 fhahl;L ePh;gpire;J nfhz;L ,ijf;Nfhop  
     jdpyilj;J apUff; fl;b 
 fhj jpUFfs;sp eWf;fpnahU ghidapl;L ePh;tpl;L  
     Nky;NtUfl;b cld;Nky; itj;J 
 Mtp Nghfhky; Nkd;%b jPnahpj;J nte;J jpwe;J thq;Nf 
 fdpa NfhopajndYk;G Nghl;L kUe;JlNd 
      rijfha;e;J tr;ufhak;gz;zp 
 
 
 
 mjDlNd ntUfbg; gpukhzq; nfhs;S gj;jpaK 
      Kg;G Gspghy; Nahuhfh 
 rptU #iyfpue;jp jPUk;re;J typtpg;GUjp cjputhA 
 fhd thjKjy; #iyNeha;jPUk; nghWj;j 
     Ff;Flhjpajp GfYNthNk 
INGREDIENTS 
 Karungozhi   - 1 in number 
 Karunjeerakam  - 35gm 
 Nareerakam   - 35gm 
 Chathipathiri  - 35gm 
 Perungayam   - 35gm 
 Milagu   - 35gm 
 Omam   - 35gm 
 Vasambu   - 35gm 
 Perarattai   - 35gm 
 Senkathari Pattai  - 35gm 
 Nayuruvi Ver  - 35gm 
 Karbokarisi   - 35gm    
 Sathikkai   - 35gm 
 Elakkai   - 35gm 
 Chukku   - 35gm 
 
 
 Thippili   - 35gm 
 Lavanga Pattai  - 35gm 
Poondu   - 35gm 
Punmurugai ver  - 35gm 
Sankan ver   - 35gm 
Paranki pattai  - 332.5gm 
METHOD OF PREPARATION: 
All raw drugs are mixed with goat urine. These are kept inside the 
cleaned cloth along with karungozhi and tied tightly. Take a mud pot and till it 
with water then add partially crushed thirugukalli samuloom. The mouth of the 
pot now closed by a cleaned cloth. The karungozhi along with drug is placed 
over the cloth and then it is boiled and streamed. Then it is dried and powdered. 
Dose  : 1.5gm 
Adjuvant : Hot water 
Pathiyam : 
 Salt, tarmarind, milk, butter milk should be avoided 
Medicinal Uses : Santhuvali, vippurathi, uthiravayu, kiranthi. 
PROPERTIES OF THE INGREDIENTS: 
1. fUq;Nfhop 
Suvai   : Inippu 
Thanmai  : Veppam 
Pirivu   : Kaarppu 
Part used  :  Flesh 
 
 
 
 
 
 
 
  
 
 
kpsF trk;G 
  
,Q;rp fUQ;rPufk; 
 
 
ngUq;fhak; ,ytq;fgl;il 
  
rPufk; [hjpf;fha; > 
[hjpgj;hp 
  
Nguuj;ij Vyk; 
  
g+z;L jpg;gpyp 
 
 
guq;fpg;gl;il nrq;fj;jhhpg;gl;il 
 
 
 
 
 
 
 
 
ACTIONS  
Stimulant 
Aphrodisiac 
CONSTITUENTS  
 Karungozhi contains many kinds of amino acids (18 kinds of amino acid 
including the 8 essential amino acids for human body). Vitamin B1, B2, B6, 
B12, C and E, niasin, protein, fat, calcium phosphorus, iron, nicotinic acid 
etc. 
 Laboratory tests show that Karungozhi contains certain hormones, blue 
pigments of amino acids, which are required by the human body. These factors 
can raise blood cells and haemoglobin. Abundance clinical experience has 
indicated that Karungozhi has a particular effectiveness in treating neurodebility 
(a condition of nervous debility suppred to be dependant upon impairment in the 
functions of the spiral cord), osteomalasia (a condition marked by softening of 
the bones), lot of hormonal problems like women's distress, sterility habitual 
abortion, blood leucorrhoea, metorrhegia and sickness after giving birth to off 
spring and also aids in curing pulmonary problems. TB, heart disease. 
 The eggs of Karungozhi have an ideal nutritive especially for old people 
and high BP victims (since the cholesterol content in lower and free amino acids 
are higher than that of other kinds of birds). 
General properties 
“Fl;lq; fbfpUkp Nfhuthjf; $l;lk;  
kl;blhr; #iyaW khjuNr – Jl;l 
 fpue;jpnahL Gz;typNghq; NfSl Yf;F  
 kUe;J fUq; NfhopA+d; it” 
 
 
 ,;e;j ghlypd;gb Nfhu thjk; NghFk; vd;gjdhy; fUq;Nfhop> thj 
Neha;fis Nghf;Ftjpy; rpwe;jJ vd mwpayhk;. 
2. fUQ;rPufk;  
               Botanical Name :  Nigella sativa 
Family  :  Ranunculaceae 
Suvai   :  Kaippu 
Thanmai  :  Veppam 
Pirivu   :  Karppu 
Part usd   :  Seed 
ACTIONS : 
Carminative 
Diuretic 
Emmenagogue 
Galactogogue 
Anthelmintic 
Stomachic 
Parasiticide 
Emollient 
CONSTITUENTS 
 The seed contains, 
 Fixed oil – 37.5% 
 
 
 Volatile oil – 1.5% 
             And albumin mucilage, metamarbin, melanthin,helleborin and 
Arabic acid 
                   Prolein – 26.7%, Oil 22.6%, ash 4.86% and total carbohydrate 40.0. 
The major unsaturated fatty acids were linokic acid (50.3 – 49.2%) , oleic acid 
(25.0 – 23.7%) and the main saturatted fatty  acid is palmitic  acid (17.2 – 
18.4%), myristic, myristoleic, palmitoleic, margaric, margaroleic, stearic, 
linolenic, arachidic, eicosenoic and lignoceric acids were also detected and 
major components of which are thymoquinone, nigellone and nigllidine. 
ew;rPufk; 
             Botanical Name    :     Cuminum cymimum 
    Family        :           Umbelliferae 
   Suvai                    :           Karppu, Inippu 
  Thanmai                :          Thatpam 
  Pirivu         :           Inippu 
  Part used         :           Seed 
 
 
ACTIONS : 
Carminative 
Stimulant  
Stomachic 
Astringent 
 
 
CONSTITUENTS 
          α – pinene, 1-8 cineole and linaloor isolatedfrom the volatile (latif et al., 
2007) Two sesquiter penoid glucosides, cuminoside A and b and z-c methyl-D-
erythritol 1-O-β-D- glucopyranoside, z-c methyl-D-erythritol 3-O-β-D- 
glucopyranoside, z-c methyl-D-erythritol 4-O-β-D- glucopyranoside and alkyl 
glycosides have been isolated from the seed. 
4. rhjpgj;hp 
 Botanical Name :  Myristica fragrans 
Family  :  Myrtacece 
Suvai   :  Thuvarppu,Karppu 
Thanmai  :  Veppam 
Pirivu   :  Karppu 
ACTIONS : 
Stimulant  
     Carminative 
Narcotic 
Aromatic 
Aphrodisiac 
Tonic 
ngUq;fhak; 
 Botanical Name :   Ferula asafoetid 
Family  :  umbelliferae 
 
 
Suvai   :  Kaippu, karakarappu 
Thanmai  :  Veppam 
Pirivu   :  Karppu 
Part used   :  Oleogumresin 
ACTIONS   
Stimulant  
     Carminative 
     Antispasmodic 
       Expectorant 
       Laxative 
      Anthelmintic 
     Diuretic 
       Aphrodisae 
     Emmenagogue 
CONSTITUENTS  
             The oleo-gum resins taste and smell are like surphur due to the presence 
of sulphur compounds like disulphides, symmetric tri and tetrasulphides, 
Glucuronic acid. Galactose, arabinosed, rhamnose, unbelliferone, farnesiferoles 
A,B, and C ferulic acid, coumarine derivaties foetidin and kamolonol have been 
isolated from oleo gum resin 
 
 
 
 
kpsF 
 Botanical Name :  Piper nigrum 
Family  :  Piper acede 
Suvai   :  Kaippu,karppu 
Thanmai  :  Veppam 
Pirivu   :  Karppu 
Part used   :  Seed, climber 
ACTIONS : 
Acrid 
       Carminative 
     Antiperiodic 
       Rubefacient 
       Stimulant  
       Resolvent 
       Antivatha 
      Antidote      
CONSTITUENTS 
                      Pyrrolidine alkamide, isopiperolein B, retrofractamide A, 
Pipercide, Pipercha barride D, Pellitorin, dehdropipernonaline, ZE,4E, 8Z 
isobutyl – eicosatrienamide, pellitorine, trachyone, pergumidiene and 
isopiperolein B have been isolated from fruit. Essential oil contained 
monoterpene hydro carbons, sabinene, β – pinene, limonene, furthermore 
 
 
terpinene, β – pinene, myrcene, 3-carene, borneol, carvone, carvacrol,1,8- 
cineol, linalool, sesqui – terpenes, β – caryophyllene, humulene, β – bisabolone, 
aryophyllene oxide ketone, phnylether, eugend, mristicin and safrole, 
bisalkaloids, dipiperamides D and E 
               Black pepper oil can be used to help in the treatment of pain relief, 
rheumatism, increase circulation, exhaustion and muscular ache. 
Xkk; 
 Botanical Name  :  Trachyspermum roxburghianum 
Suvai   :  karppu 
Thanmai  :  Veppam 
Pirivu   :  Karppu 
Part used   :  Seed 
ACTIONS : 
Stomachic 
Antispasmodic 
Carminative 
Antiseptic 
Stimulant 
Tonic  
Sialogogue      
 
 
 
 
CONSTITUENTS 
                The essential oil of the seed contained terpinene, p – cymene,  α – 
pinene, thymol and carvacrol. The seed has steroptis, cumene, thymine, 
aminoacids, threonine, calcium, iron, starch, tannins and dietary fibre. The seed 
contain an essential oil containing about 50% thymol which is strong germicide, 
antispasmodic and fungicide. Thymol is also used in toothpaste and perfumery 
trk;G 
 Botanical Name :  Acorus calamus 
  Suvai      :  karppu 
  Thanmai      :  Veppam 
  Pirivu      :  Karppu 
  Part used       :  Root 
ACTIONS : 
 Stimulant 
 Stomachic 
 Antispasmodic 
 Carminative 
  Nauseant 
  Emetic 
  Disinfectant 
 
 
 
 
Nguuj;ij: 
 Botanical Name :  Alpina galanga 
   Family      :  Zingiberaceae 
   Suvai      :  karppu 
        Thanmai      :  Veppam 
   Pirivu      :  Karppu 
Part used       :  Root 
ACTIONS : 
    Expectorant 
    Febrifuge 
    Stomachic 
CONSTITUENTS 
  1’S- 1autoxychavicol acetate, P – hydroxycinnamaldehyde and methane 
were isolated from the rhizome and to possess various biological activies such 
as antitumour. The essential oil contained monoterpenes, monoterpene alcohols, 
esters, sesquiterpenes, methyleugenol, eugenol, acetate, chavicol and chavicol 
acetate were identified. 
nrq;fj;jhhpg; gl;il: 
 Botanical Name :   Capparis Sepiaraia 
Family  :  Capparidace 
Suvai   :  Thuvarppu 
Thanmai  :  Thatpam 
 
 
Part used   : Bark. 
ACTIONS : 
Stomachic 
Tonic 
 
CONSTITUENTS: 
Capparine, cappariline and capparinine were isolated from roots. 
ehAUtp 
 Botanical Name :   Achyranthes aspera 
  Family      :  Amaranthaceae 
    Suvai     : Kaippu,Thuvarppu,Karppu 
  Thanmai     :  Veppam 
 Pirivu     :  Karppu 
 Part used     :   Root 
ACTIONS : 
Astringent 
Diuretic 
Alterative 
Antiperiodic 
 
 
 
 
CONSTITUENTS: 
           Aliphatic    dihydroxy ketone, characterized as 36,47 dihydroxy henpenta 
contan – 4-one, tritria contanol, achyrathine pantatriacontan, 6-pentatria 
contanone, hexatria contane and triacontane 
Nguuj;ij 
    Botanical Name  : Alpinia galangal 
   Family   : Zinigiberaceae. 
   Suvai   : Karppu 
   Thanmai   : Veppam 
   Pirivu   : Karppu 
  Part used   : Root 
ACTIONS 
Expectorant 
Febrifuge 
Stomachic 
CONSTITUENTS: 
 1’S-1 acetoxychavicol acetate, P-hydroxycinnamadehyde and nethane 
were isolated from the rhizome and to possess various biological activities such 
as antitumour. The essential oil contained monoterpenes, monoterpene alcohols, 
esters, sesquiterpenes, methyleugenol, eugenol acetate, chaviol and chavical 
acetate were identified. 
 
 
 
 
fhh;Nghfhprp 
 Botanical Name  :   Psoralia corylifolia 
Family       :  Fabaceae 
Suvai   :  Kaippu 
Thanmai   :  Veppam 
ACTIONS: 
          Laxative  
          Stimulant 
CONSTITUENTS: 
               Psoralidin, bakuchicin, psoralin, angelicin, Psoracorylifols A-E, 
Prenylflavonoids, corylifols A and C were isolated from the seeds and they 
showed significant antibacterial activities against a number of Gram(-) and 
Gram(+) bacteria.  Isobavachalwne neobavaisoflavone, isopsoralen and 
psoralen were obtained from the seed. 
Vyf;fha; 
Botanical Name  : Elatteria Cardamomum 
Suvai                :  Karppu 
Thanmai           :  Veppam 
Pirivu               :  Karppu 
Part used           :  Seed 
 
 
 
 
ACTIONS: 
             Stimulant 
              Carminativc 
               Stomachic 
Rf;F 
Botanical Name  :  Zingiber officinale 
Family               :   Zingiberaceae 
Suvai                :  Karppu 
Thanmai            :  Veppam 
Pirivu                :  Karppu 
Part used           :  Rhizome (dried) 
ACTIONS: 
                  Stimulant 
                  Stomachic 
                  Carminative. 
CONSTITUENTS: 
                  Ginger is known to contain a number of potentially bioactive 
substances mainly gingerols shogabls, sesquiterpenes, B-bisabliene, 
Zingiberene, Zingiberol, Curcumene, monoterpenes, geraial and neral  
 
 
 
 
jpg;Gyp 
Botanical Name  :  Piper longum 
Family      :  Piperaceae. 
Suvai                    :  Inippu 
Thanmai             :  Veppam 
Pirivu                  :  Inippu 
Part used               :  Seed. 
ACTIONS: 
                  Astringent 
                  Expectorant 
                  Laxativc 
                  Tonic. 
CONSTITUENTS: 
               Guineensine, pipernonaline, pellitorine, piperine, piperanine, 
piperidine alkaloids pipermonaline, piperundecalidine brachyamide A, 
brachyamide B and brachystine and piperlonguminine were isolated from fruit.  
Piperlongumine and piperlingumine and sesamin isolated from fruits. 
,ytq;fg;gl;il 
Botanical Name  :  Cinnamomum Verum 
Suvai                   : Karppu, Inippu 
Thanmai               :  Thatpam 
Pi rivu                  :  Inippu 
 
 
Part used              :  Bark 
ACTIONS: 
                 Stimulant 
                 Carminative 
                  Aphrodisiac 
G+z;L 
Botainical Name  : Allium Sativum 
Family  : Liliaceae 
Suvai                :  Karppu 
Thanmai          : Veppam 
Pirivu               :  Karppu 
Part used          :  Tuber 
ACTIONS: 
                  Carminative 
                   Stomachic 
                   Tonic 
                   Alterative 
                   Stimiulant 
                   Expectorart 
                   Diurctic 
                   Anthelmintic 
 
 
CONSTITUENTS: 
                    Sulphus compounds including allicin, premethanethiosulfonate 
Dithun derivatives dially sulphide, diallyl trisulfide, proto-eruboside  B, 
Spirostanol, sativoside  B1 analogue, eruboside  B, rutin, quercetin 3 glucoside, 
quercitrin myricetin, luteolin, quercetin, apigenin, kaempferol and isorhamnetin 
Gd;KUq;if 
Botanical Name : Moringla tinctoria 
Family                : Rubianceae 
Part used           : Root. 
gwq;fpg;gl;il: 
Botaical Name: Smilax china 
Family              :Liliaceae 
Suvai                : Inippu 
Thanmai           : Thatpam 
Pirivu                : Inippu 
Part used           : Tuber 
ACTIONS: 
          Alterative 
          Antisyphilitic 
          Aphrodisiac 
           Depurative 
 
 
 
CONSTITOENTS: 
            Six major stilbenes and flavonoids namelytaxifolin-3-0-glycoside, 
piceid, oxyresveratrd, engeletin, resevertrol and scirpusin A have been isolated 
from root tubers saponins, smilaxin, prosapogemin A, dioscin, gracilin, 
dioscin, pseudoprotodioscin, methugracillin and methyl protodioscin have been 
reported from root. 
rq;fd;Nth; 
Botanical Name  : Azima tetracantha 
Suvai    : Kaippu 
Thanmai   : Veppam 
Pirivu    : Kaippu 
Part used   : Root 
ACTIONS 
 Diuretic 
 Stimulant 
 Astringent 
 Tonic 
 Antiperiodic 
 Expectorant 
 
 
 
 
 
PREPARATION AND PROPERTIES OF TRIAL MEDICINE 
Name of the trial medicine :  KARUNGOZHI CHOORANAM 
EXTERNAL DRUG: 
 VIDAMUTTI THYLAM 
INGREDIENTS: 
 Etti fruit juice  : Required quantity 
 Gingelly oil   : 1.3 it 
 Castor oil   : 1.3 it 
 Lime juice   : 1.3 it 
 Etti Kottai powder  : 1.3 it 
METHOD OF PREPARATION: 
 “vl;bAWk; goj;ijnahU ghidajp 
 dpiuj;jdp ypire;jfhb 
 tpl;nlhUjhw; wpdKW itj;jijf;if 
 ahw;gpire;J tpsk;GJ}rhw; 
 wpl;lKw tbfl;bf; nfhz;lnjhU 
 FWzpajpw; wpjo;ey;z;nza; 
 apl;lKw tpuz;Lgb nahUgbNah 
 kzf;nfz;nz apirar;Nru 
 NruYkpr; rk;gor; rhnwhUgbAQ; 
 Nrh;e;jjd;gpd; nrg;Gnkl;bg; 
 
 
 ghuKWq; nfhl;ilaJk; gbapbj;Jg; 
 Nghl;nlhpj;Jg; gjj;jpw; fha;r;rpr; 
 rhuKw ypbj;Jf; nfh spdjd;Nghpy; 
tplKl;bj; ijykhFk; 
ghUyNfhh;f; fpijj; njhl;Lj; jltpby;yh 
jq;fnsy;yhk; gwf;Fk;ghNu 
METHOD OF PREPARATION: 
Etti Fruits are soaled in kaddi (Vinegar) for 4 days. Now it is crushed to get 
juice. Then it is added with gingelly oil, castor oil and lime juice and powdered 
form of etti kottai.Then it is heated till the drugs tum to red. Then filter the oil 
and use it for external purposes. Three following books also describe and deal 
with the same condition. 
  
 
 
ANNEXTURE - II 
BIO - CHEMICAL ANALYSIS OF   
KARUNGOZHI CHOORANAM 
Preparation of the extract: 
5gms of KARUNGOZHI CHOORANAM   was weighed accurately 
and placed in a 250ml clean beaker. Then 50 ml distilled water is added to it 
and dissolved well.  Then it was boiled well for about 10 minutes. It was cooled 
and filtered in a 100 ml volumetric flask and then it is made up to 100ml with 
distilled water. This fluid is taken for analysis. 
Qualitative analysis  
S.No. Experiment Observation Inference 
1. Test for calcium 
2ml of the above prepared extract 
is taken in a clean test tube.  To 
this add 2 ml of 4% ammonium 
oxalate solution. 
A  white 
precipitate is 
formed. 
Indicates the 
presence of 
calcium. 
2. Test for sulphate: 
2ml of the extract is added to 5% 
barium chloride solution. 
A white 
precipitate is 
formed. 
Indicates the 
presence of   
sulphate. 
3. Test for chloride 
The extract is treated with silver 
nitrate solution. 
A white 
precipitate is 
formed. 
Indicates the 
presence of 
chloride. 
4. Test for carbonate 
The substance is treated with 
concentrated HCl. 
No brisk 
effervescence is 
formed. 
Absence of 
carbonate. 
 
 
5. Test for Starch 
The extract is added with 
potassium ferro cyanide. 
No blue colour 
is formed. 
Absence of 
starch. 
6. Test for iron Ferric 
The extract is treated with 
concentrated glacial acetic acid 
and potassium ferro cyanide. 
No blue colour 
is formed. 
Absence of 
ferric iron. 
7. Test for iron Ferrous: 
The extract is treated with 
concentrated nitric acid and 
ammonium thio cyanate. 
Blood red colour 
is formed. 
Indicates the 
presence of 
ferrous iron. 
8. Test for phosphate 
The extract is treated with 
ammonium molybdate and 
concentrated nitric acid. 
Yellow 
precipitate is 
formed. 
Indicates the 
presence of 
phosphate. 
9. Test for albumin 
The extract is treated with 
Esbach’s reagent. 
No yellow 
precipitate is 
formed. 
Absence of 
Albumin. 
10. Test for Tannic acid 
The extract is treated with ferric 
chloride reagent. 
No Blue black 
precipitate  is 
formed 
Absence of   
Tannic acid 
11. Test for unsaturation 
Potassium permanganate solution 
is added to the extract. 
It gets 
decolorized. 
Indicates the 
presence of 
unsaturated 
compound. 
12. Test for the reducing sugar 
5ml of benedict’s qualitative 
solution is taken in a test tube and 
allowed to boil for 2 mts and 
added 8-10 drops of the extract 
and again boil it for 2 mts. 
No Colour 
change occurs. 
Absence of 
reducing sugar 
 
 
13. Test for amino acid: 
One or two drops of the extract 
are placed on a filter paper and 
dried it well. After drying, 1% 
ninhydrin is sprayed over the 
same and dried it well. 
Violet colour is 
formed. 
Indicates the 
presence of 
Amino acid. 
14. Test for zinc: 
The extract is treated with 
potassium ferrocyanide 
No white 
precipitate  is 
formed 
Absence of zinc 
 
Result: 
The trial drug  KARUNGOZHI CHOORANAM contains, 
1. calcium 
2. sulphate 
3. chloride 
4. ferrous iron 
5. phosphate 
6. unsaturated compound 
7. amino acid. 
 
  
 
 
ANNEXURE – III 
GOVT SIDDHA MEDICAL COLLEGE, 
PALAYAMKOTTAI 
PHARMACOLOGICAL ANALYSIS 
ANALGESIC STUDY OF 
KARUNGOZHI CHOORANAM 
Aim: 
To study the effects of analgesic action on albino rates by tail flick 
method. 
Instruments: 
Analgesiometer using heated nicrome wire as the source of stimulus. 
Procedure: 
Two groups of rates on either sex were selected, each group having three 
rats and each rat was put inside a rat holder with the tail projecting out fully. 
The tip of the tail was kept over the nicrome wire of the analgesiometer.  To 
heat the nicrome wire by switching in on and at the same time starting a 
stopwatch.  The time takes for the rat to flick the tail was noted.  This was kept 
as the control volume. 
Paracetamol was administered at a dose of 20 mg/100gm of a body 
weight oraly to the test group.  The reaction time was noted after the 
administration half an hour and one hour and the average is calculated. 
When a rat fails to flick the tail, it should be continued beyond eight 
seconds to avoid injury. 
The result of drug treated group and control group were tabulated and 
compared. 
  
 
 
 
STUDY OF ANALGESIC EFFECT USING THE DRUG                    
KARUNGOZHI CHOORNAM 
 
Group 
Dose / 
100mg Body 
weight 
Initial 
reading 
(in Sec) 
After ½ 
hour  
(in Sec) 
After 1  ½ 
hour  
(in Sec) 
 
Mean 
Difference 
Control Water 2 ml 
 
2 
 
2 2 
 
2 
 
Standard 
Paracetomol                 
20 mg 
 
2.5 
 
4.5 6.5 6.5 
Test drug 
 
Karungozhi 
chooranam 
100mg 
2.5 
 
4.0 
 
5.8 
 
5.8 
 
Inference: 
The trial drug has significant analgesic action.  
ACUTE ANTI – INFLAMMATORY ACTIVITY  IN  RATS 
BY HIND – PAW METHOD 
Aim: 
To demonstrate the acute anti-inflammatory activity of  Karungozhi 
Chooranam in albino rats by Hind-paw method. 
Procedure: 
Nine Albino rats weighing 100-150gm were taken and divided into three 
groups and each group consisting three rats.  
First group was kept as control land received water. Second group 
received lbuprofen at a dose of 20mg/100gm – body weight.  Third group 
animals received Karungozhi Choornam   suspension at a dose of 200mg/ 100 
gm – body weight. 
 
 
Before administration of drugs, the Hind-paw upto the tibio-tarsal 
junction in mercury plethysmograph.  Soon after the measurement at the drugs 
were administered.  One hour after the administration of drugs a sub – 
cutaneous injection of 0.1ml of 1%/W/N of carrageenin in water was made into 
planter surface of both the Hind-paw of each rat. 
Three hours after carrageenin injection, the Hind-paw volume was 
measured once again. Difference between the initial and final value were noted 
and compared. 
This method is more suitable for studying anti-inflammatory activity in 
acute inflammation. 
EFFECTS OF KARUNGOZHI CHOORANAM   IN 
ACUTE ANTI – INFLAMMATORY ACTIVITIES 
Group 
Dose volume 
orally 
Initial 
reading 
Final 
reading 
Mean 
difference 
Percentage 
Inflammation 
Percentage 
Inhibition 
Control Water 2 ml 0.55 1.4 0.85 100 - 
Standard 
Ibuprofen 
20mg/100gm 
0.55 0.75 0.20 23.5 76.5 
Test drug 
Karungozhi 
chooranam 100mg 
/ 100gm 
0.57 0.89 0.32 37.6 62.4 
 
Result: 
 The drug Karungozhi Chooranam   has Significant acute anti-
inflammatory action. 
  
CHRONIC ANTI-INFLAMMATORY STUDY 
BY COTTON – PELLETS GRANULOMA METHOD 
Drug: 
 Karungozhi Chooranam 
 
 
 
Aim: 
 To study the chronic ani-inflammatory activity of the drug in albino rats 
by cotton pellets implantation (granuloma) method. 
Procedures: 
 Cotton pellets each weighing long was prepared and sterilized in an 
autoclave for about one hour under 15 lbs atmosphere pressure.  Nine Albino 
rats weighing between 100-200gm were selected and were divided into 3 
groups.  Each rat was anaesthetized with ether and cotton pellets were implanted 
subcutaneously in the groin, two in each side. 
 From the day of implantation, one group of animals received 
Karungozhi Chooranam  at a dose of 200mg/100gm of body weight. 
 On the eighth day the rats were sacrificed and the pellets were removed 
weighed.  Then they were put in an incubator at 600C-800C and then weighed. 
The concordant weight was noted for all groups and compared. 
THE EFFECT OF KARUNGOZHI CHOORANAM  IN CHRONIC   
ANTI – INFLAMMATORY STUDY 
Group 
Dose given 
orally 
Pellet 
Weight 
Pellet Weight of 
the Granuloma of 
drugs 
Percentage 
inflammation 
Percentage 
inhibition 
Control Water 1ml 10mg 250 mg 100 - 
Standard 
Ibuprofen 
20mg/100gm 
body weight 
10mg 55mg 22 78 
Test 
drug 
100mg/100gm 
body weight 
10 mg 98mg 40 60 
 
Inference: 
 The drug Karungozhi Chooranam shows Significant chronic   
anti – inflammatory action. 
 
 
ACUTE ANTI - INFLAMMATORY STUDY ON 
VIDAMUTTI THYLAM (EXTERNAL USE) BY HIND-PAW 
METHOD IN ALBINO RATS 
Aim: 
 To study the acute anti-inflammatory activity of the test drug 
Vidamutti thylam 
Procedure: 
Six healthy albino rats weighing 100-150gm were taken and divided into three 
groups, each consisting of 2 rats. 
First group was kept as control by giving distilled water of 2ml/100gm of 
body weight. The second group was kept as test group. The third group was given the 
standard drug. 
Before application of the test drug the Hind-paw volume of all the rats were 
measured. This was done by dipping the Hind-paw (up to the tibio-femoral 
junction) into a mercury plethysmograph. While dipping the Hind-paw, by pulling 
the syringe piston, the level of mercury in the centre small tube was made to coincide 
with red marking and reading was noted from the plethysmograph. 
One hour later, a sub-cutaneous injection of 0.1ml of l%(w/r) 
Carrageenin water made into plantar surface of both Hind-paw of each rat. To 
the second (last) group Vidamutti thylam was topically applied for three 
times over the inflammed surface in a thin layer for every 15mts for an hour. 
To the other group no drug was applied over the inflammed surface. 
Three hour after injection the Hind-paw volume was measured once 
again.  The difference between the initial and final volume would show the 
amount of inflammation.  Taking the volume in the control group as 100% of 
inflammation, anti – inflammatory effect of the test group is calculated. 
 
  
 
 
 
 
 
EFFECT OF VIDAMUTTI  THYLAM     
Group Drugs 
Dose 
100 
gm of 
body 
weight 
Initial 
value 
Final 
value 
Difference 
Percentage 
Inflammation 
Percentage 
Inhibition 
Control Water 2ml 0.55 1.4 0.85 100 - 
Standard Ibuprofen 20mg 0.55 0.75 0.20 29.4 70.6 
Test 
drug 
Vidamutti Thylam Ext  0.525 0.8 0.275 40.44 59.56 
 
 
Inference: 
  The test drug has significant anti-inflammatory action externally. 
 
ANALGESIC STUDY OF VIDAMUTTI  THYLAM    
Aim: 
To study the effects of analgesic action on albino rates by tail flick 
method. 
Instruments: 
 Analgesiometer using heated nicrome wire as the source of stimulus. 
Procedure: 
 Two groups of rates on either sex were selected, each group having three 
rats and each rat was put inside a rat holder with the tail projecting out fully. 
The tip of the tail was kept over the nicrome wire of the analgesiometer.  To 
heat the nicrome wire by switching in on and at the same time starting a 
stopwatch.  The time takes for the rat to flick the tail was noted.  This was kept 
as the control volume. 
 Paracetamol was administered at a dose of 20 mg/100gm of a body 
weight oraly to the test group.  The reaction time was noted after the 
administration half an hour and one hour and the average is calculated. 
 
 
 When a rat fails to flick the tail, it should be continued beyond eight 
seconds to avoid injury. 
 The result of drug treated group and control group were tabulated and 
compared. 
 STUDY OF ANALGESIC EFFECT USING THE DRUG   
VIDAMUTTI    THYLAM                     
 
Group 
Dose / 100mg 
Body weight 
Initial 
reading (in 
Sec) 
After ½ 
hour  
(in Sec) 
After 1  
½ hour  
(in Sec) 
 
Mean 
Difference 
Control Water 2 ml 2 2 2 
 
2 
Standard 
Paracetomol                 
20 mg 
 
2.5 
 
4.5 6.5 6.5 
Test Drug  
 
2ml 
2 
 
3 
 
5 
 
5 
 
Inference: 
The trial drug has significant analgesic action. 
 
  
 
 
ANNEXURE – IV 
ASSESSMENT FORMS 
 
FORM I - SCREENING FORM 
FORM II - CONSENT FORM 
FORM III - CASE  PROFORMA 
FORM IV - LABORATORY INVESTIGATIONS 
FORM V - CLINICAL ASSESSMENT 
FORM VI -  PATIENT WITHDRAWAL FORM 
FORM 
VII 
- DRUG COMPLIANCE FORM 
 
 
  
        
       
        
       
 
 
 
 
 
GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL 
PALAYAMKOTTAI. 
POST- GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
AN OPEN CLINICAL TRIAL OF KARUNGOZHI  CHOORANAM & 
VIDAMUTTI  THYLAM FOR AZHAL KEEL VAAYU 
(OSTEOARTHRITIS) 
FORM I –SCREENING FORM 
 
 1. OP/ IP No:                                                  2. BED No:                   
 3. Sl. No:            4.   NAME:  
5. AGE:                                         6. GENDER:  
 7.   OCCUPATION:                                       8. SOCIAL STATUS 
9.  DATE OF ADMISSION:                          10. DATE OF DISCHARGE: 
11. POSTAL ADDRESS: 
 
 
 
 
I. INCLUSION CRITERIA: 
1. Sex:  Both Male and Female. 
2. Pain and swelling present in knee joints. 
3. Crepitations present in knee joints.   
4. Early morning stiffness. 
5.  Tenderness 
II. EXCLUSION CRITERIA: 
1. Diabetes Mellitus 
2. Hypertension  
3. Cardiac diseases 
4. Pregnancy and Lactation 
5. Patients with any other serious illness 
6. Peptic ulcer 
7. Severe trauma 
8. Any other systemic diseases 
 III. WITHDRAWAL CRITERIA: 
               1. Development of any adverse reaction (ADR 
                2. Occurrence of any other systemic illness. 
 
 
 
 
GOVERNMENT SIDDHA MEDICAL COLLEGE AND  HOSPITAL 
PALAYAMKOTTAI. 
POST- GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
AN OPEN CLINICAL TRIAL OF KARUNGOZHI  CHOORANAM & 
VIDAMUTTI  THYLAM FOR AZHAL KEEL VAAYU 
(OSTEOARTHRITIS) 
Form: II CONSENT FORM 
CERTIFICATE BY INVESTIGATOR 
 I certify that I have disclosed all the details about the study in the terms readily 
understood by the patient. 
Signature………………….          Date……                                                                                                                                                                                                                
Name…………………… 
 
CONSENT BY PATIENT 
 
I have been informed to my satisfaction, by the attending physician, the 
purpose of the clinical trial, and the nature of drug treatment and follow-up 
including the laboratory investigations to be performed to monitor and 
safeguard my body functions.  
I am aware of my right to opt out of the trial at any time during the course 
of the trial without having to give the reasons for doing so. 
 
 
I, exercising my free power of choice, hereby give my consent to be 
included as a subject in the clinical trial of ‘KARUNGOZHI  CHOORANAM 
(Internal drug & VIDAMUTTI  THYLAM (External drug)’ for the treatment of 
‘Azhal keel vaayu’ (osteoarthritis). 
 
Signature………………….          Date……………….                                                                                                                                                                                                                
Name………………… 
murpdH rpj;j kUj;Jtf; fy;Y}hp kw;Wk; kUj;Jtkid>ghisaq;Nfhl;il 
gl;lNkw;gbg;G rpwg;GkUj;Jtj;Jiw 
 'fUq;Nfhop #uzk;" kw;Wk; 'tplKl;b ijyk;" ,tw;wpd; 
gupfupg;Gj;jpwidf; fz;lwpAk; kUj;Jt Ma;T 
Xg;Gjy; gbtk; 
 
 
Ma;thsuhy; rhd;wspf;fg;gl;lJ 
 
 ehd; ,e;j Ma;itf; Fwpj;j midj;J tpguq;fisAk; Nehahspf;F 
GupAk; tifapy; vLj;Jiuj;Njd; vd cWjpaspf;fpNwd;. 
 
Njjp:                                 ifnahg;gk;: 
,lk;:                                   ngau;: 
 
 
Nehahspapd; xg;Gjy;                   
 vd;dplk; ,e;j kUj;Jt Ma;tpd; fhuzj;ijAk; kUe;jpd; jd;ik 
kw;Wk; kUj;Jt topKiwiag; gw;wpAk; njhlu;e;J vdJ cly; 
,af;fj;ij fz;fhzp;f;fTk>; mjidg; ghJfhf;fTk; gad;gLk; kUj;Jt 
Ma;Tf;$l gupNrhjidfs; gw;wpAk; jpUg;jp mspf;Fk; tifapy; Ma;T 
kUj;Jtuhy; tpsf;fpf; $wg;gl;lJ. 
ehd; ,e;j kUj;Jt Ma;tpd; NghJ fhuzk; vJTk; $whky; 
vg;nghOJ Ntz;LkhdhYk; ,e;j Ma;tpypUe;J vd;id tpLtpj;Jf; 
nfhs;Sk; cupikia njupe;jpUf;fpd;Nwd;. 
 ehd; vd;Dila Rje;jpukhfj; Nju;T nra;Ak; cupikiaf; nfhz;L 
moy; fPy; thA vd;Dk; Neha;f;fhd ‘fUq;Nfhop #uzk; ” kw;Wk; ‘ 
tplKl;b ijyk; “ Mfpatw;wpd;  gupfupg;Gj; jpwidf; fz;lwpAk; 
kUj;Jt Ma;tpw;F vd;id cl;gLj;j xg;Gjy; mspf;fpNwd;. 
Njjp:                                     ifnahg;gk;:
,lk;:                                  ngau;: 
Njjp:                          rhl;rpf;fhuh; ifnahg;gk;: 
,lk;:                                        ngau;
 
 
 
GOVERNMENT SIDDHA MEDICAL COLLEGE AND  HOSPITAL 
PALAYAMKOTTAI. 
POST- GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
AN OPEN CLINICAL TRIAL OF KARUNGOZHI  CHOORANAM & 
VIDAMUTTI  THYLAM FOR AZHAL KEEL VAAYU 
(OSTEOARTHRITIS) 
FORM III – CASE PROFORMA 
1. OP/ IP No:                                           2. BED No:                            3. Sl. No:  
 4.   NAME:                                              5. AGE:                                  6. GENDER:  
 7.   OCCUPATION:                                    8. SOCIAL STATUS 
9.  DATE OF ADMISSION:                        10. DATE OF DISCHARGE: 
11. POSTAL ADDRESS: 
 
12. COMPLAINTS & DURATION:    
13. HISTORY OF PRESENT ILLNESS:  
Lecturer                         HOD 
 
 
14. PAST HISTORY:  
15. FAMILY HISTORY: 
16. MENSTRUAL HISTORY (If applicable):  
17. HABITS:                                  Yes               No                                                                                                                                                                                             
1. Smoker     
2. Alcoholic 
3. Betel nut chewer 
4. Non-Veg /Vegetarian      
5. Drug addiction                                 
18. GENERAL EXAMINATION: 
1. Body weight [Kg]         :                      
2. Height [cm]                        :                      
3. Body Temperature [oF]        :   
4. Blood Pressure (mmHg)  :      
5. Pulse Rate /min.   : 
6. Heart Rate /min.    : 
7. Respiratory Rate /min.  :   
         
 
 
 
                                                     Yes            No   
8. Pallor : 
9. Jaundice :   
10. Clubbing : 
11. Cyanosis : 
12. Pedal Oedema : 
13. Lymphadenopathy    :                                        
14. Jugular venous pulsation:  
19. CLINICAL EXAMINATION OF KNEE JOINT: 
I. INSPECTION                        Present     Absent 
        1. Swelling     …………………………… 
        2. Muscle wasting     …………………………… 
        3. Deformity      …………………………… 
II. PALPATION: Present       Absent 
    1. Tenderness           ………………………….. 
    2. Swelling          ……………………………  
 
 
    3. Crepitations           …………………………… 
  4. Warmth                    ......……………………… 
III. MOVEMENTS:  
1. Restriction of Movements in the Knee joint:  Full    Partial             No 
2. KNEE:  PAIN  MUSCULAR SPASM ROM 
                                          Yes   No        Yes      No           Normal        Reduced 
    i. Flexion       
         ii. Extension 
3. NEUROLOGICAL EXAMINATION: 
   i. Sensation  Normal                     Abnormal                  
   ii. Tone                         Normal                  Abnormal                   
  iii. Power                      Normal                    Abnormal                  
  iv.Muscle wasting  Present                   Absent                      
 
 
4. REFLEXES:                      Normal    Exaggerated  
        i. Knee jerk 
        ii. Ankle jerk 
20. CLINICAL ASSESSMENT: 
I. PAIN: 
A. Pain in the knee joints:       No            Mild                  Moderate         Severe  
       
          i. Onset         Sudden                       Gradual              
         ii. Nature:         Local                           Diffuse        Others 
B. Nature of pain   Shooting                       Burning       Others 
   YES                NO 
C. Pain during movements          
II. Morning stiffness 
 
 
III.Tenderness                                                                                                                                                                       
III. Swelling             
IV. Restricted joint movements                                                                                              
21. EXAMINATION OF OTHER SYSTEMS: 
     Normal       Abnormal 
1.  CVS  
2.  RS    
3.  CNS 
4. ABDOMEN   
            5.  GENITO-URINARY                                         
  
 
 
SIDDHA ASPECTS 
1. NILAM: 
       1. Kurinji            2. Mullai          3. Marutham       4. Neithal           5. Paalai 
2 . KAALAM: 
         1. Kaar Kaalam    2. Koothir Kaalam          3. Munpani Kaalam     
         4. Pinpani Kaalam          5. Ilavenir Kaalam        6. Muduvenir Kaalam 
3. YAAKKAI: 
 1. Vatham          2. Pitham      3. Kabam     
4. Vathapitham        5. Pithavatham    6. Kabavatham       
7. Vathakabam        8. Pithakabam              9. Kabapitham    
4. GUNAM: 
 1. Sathuvam  2. Rasatham             3. Thamasam 
 
 
 
 
5. IYMPORIGAL:     Normal   Affected   
1.  Mei                                   ..………………………………….. 
2. Vaai                                    ……………………………………... 
3.  Kan                                   ……………………………………… 
4. Mookku                             ……………………………………… 
5.  Sevi                                   ……………………………………… 
6. KANMENDHIRIUM / KANMAVIDAYAM: 
   Normal   Affected    
1. Kai                                            …………………………………………... 
2. Kaal                                          …………………………………………... 
3. Vaai                                           ………………………………………….. 
4. Eruvaai                                      …………………………………………..  
5. Karuvaai                                    ………………………………………….. 
 
 
 
 
7. UYIR THATHUKKAL: 
I. VATHAM:     Normal    Affected 
1. Piraanan                                      ………………………………………… 
2.  Abaanan                                    ………………………………………….    
3. Viyaanan                                 ………………………………………….   
4.  Uthaanan                                    ……………………………………    
5. Samaanan                                    ……………………………………                             
6. Naagan                                      ……………………………………….    
7. Koorman                                  …………………………………………...  
8. Kirukaran                                   …………………………………………...         
9. Devathathan                               …………………………………………     
10. Dhananjeyan                            …………………………………………  
 
 
 
 
II. PITHAM :             Normal    Affected 
1. Analam                                     ……………………………………….         
2. Ranjagam                                 ………………………………………….   
3. Saathagam                                  ………………………………………..     
4. Aalosagam                                 ……………………………………….           
5. Prasagam                                   …………………………………….. 
III. KABAM:     Normal    Affected 
1. Avalambagam                       …………………………………………… 
2. Kilethagam                             …………………………………………… 
3. Pothagam                                 …………………………………………… 
4. Tharpagam                               ……………………………….…………... 
5. Santhigam                                …………………………………………… 
 
 
 
 
8. UDAL THATHUKKAL: Normal   Affected 
1.  Saaram                                                     ……………………………… 
2. Senneer                                                ……………………………… 
3.  Oon                                                                 ……………………………. 
4.  Kozhuppu                                                       ……………………………. 
5. Enbu                                                                ……………………………. 
6. Moolai                                                             …………………………… 
7. Sukkilam/Suronitham                                   ……………………………. 
9. ENVAGAI THERVUGAL: 
 1 . Naadi    ……………………………………………………. 
                              Normal    Affected 
2. Sparisam                                           ………………………….. 
3. Naa                                                       …………………………… 
4. Niram                                            …………………………….. 
5. Mozhi                                                      …………………………….. 
 
 
6. Vizhi                                                        …………………………….. 
7. Malam 
      a. Niram                                  …………………………….. 
      b. Nurai                                   …………………………….. 
      c. Kirumi                    .…………………………….. 
      d. Thanmai:    i. Irugal                 ii. Ilagal                           
  8. Moothiram: 
I. NEERKKURI   Normal    Affected 
     a. Niram                             …………………………….. 
     b . Manam                      …              …………………………….. 
     c. Edai                       …………………………….. 
     d. Nurai                    …………………………….. 
     e. Enjal                                             …………………………….. 
II. NEIKKURI: ………………………………………. 
          Vatha Neer             Pitha Neer            Kaba Neer 
 
 
GOVERNMENT SIDDHA MEDICAL COLLEGE AND  HOSPITAL 
PALAYAMKOTTAI. 
POST- GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
AN OPEN CLINICAL TRIAL OF KARUNGOZHI CHOORANAM & 
VIDAMUTTI THYLAM  FOR AZHAL KEEL VAAYU 
(OSTEOARTHRITIS) 
Form IV - LABORATORY INVESTIGATIONS 
1. OP/ IP No:                                      2. BED No:                           3. Sl. No:  
 4.   NAME:                                          5. AGE:                                 6. GENDER:  
 7.   OCCUPATION:                                        8. SOCIAL STATUS 
9.  DATE OF ENROLMENT:                        10. DATE OF DISCHARGE: 
11. POSTAL ADDRESS: 
 
Date: 
 
 
Lecturer                         HOD 
 
 
I. BLOOD: 
1. TC :    (Cells/Cumm)          
2. DC (%):   N                L                        M            E                      
3. ESR (mm) :    ½ hr                           1 hr 
4. Hb:  
5. Total RBC:                
6. Blood Sugar:   a) Fasting                       b) Post prandial                         
7. Kidney function tests: 
              Blood urea:   Serum creatinine: 
8. Lipid profile: 
              HDL:    LDL:              VLDL: 
  
              Total Cholesterol :  TGL: 
9. Liver Function tests: 
              SGOT:   SGPT:   Alk. Phosphatase: 
               Albumin:   Globulin:  Total Protein: 
               Serum Bilirubin:         Total  Direct Indirect : 
     
 
 
  II. URINE: 
1. Albumin :                                                    
2. Sugar :                                                           
3. Epithelial cells   :                 
4. Pus cells             :                 
5. Red blood cells  :                 
6. Casts/Crystals    : 
III. MOTION:    
1. Ova    : 
2. Cyst    : 
3. Occult blood   : 
4. Pus cells   : 
IV. X-RAY: 
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(OSTEOARTHRITIS) 
FORM V – CLINICAL ASSESSMENT 
1.  OP/ IP No:                             2. BED No:                           3. Sl. No:  
 4.   NAME:                                 5. AGE:                                 6. GENDER:  
 7.   OCCUPATION:                                        8. SOCIAL STATUS 
9.  DATE OF ADMISSION:                          10. DATE OF DISCHARGE: 
11. POSTAL ADDRESS: 
 
 
 
Lecturer                         HOD 
 
 
CLINICAL EXAMINATION OF KNEE JOINT: 
I. INSPECTION:                    Present      Absent 
        1. Swelling     …………………………… 
        2. Muscle wasting     …………………………… 
        3. Deformity      …………………………… 
II. PALPATION: Present            Absent 
    1. Tenderness            ……………………… 
    2. Swelling              …………………………  
    3. Crepitations     ……………………………… 
  4. Warmth               
……………………………… 
 
 
 
 
 
III. MOVEMENTS:  
1. Restriction of Movements in the Knee joint:  Full Partial         No 
2. KNEE:  PAIN MUSCULAR SPASM ROM 
                                       Yes   No        Yes   No                Normal    Reduced 
            i. Flexion  
            ii. Extension 
3. NEUROLOGICAL EXAMINATION: 
           i. Sensation: Normal                             Abnormal                  …………... 
            ii. Tone         Normal                        Abnormal                  ………….. 
             iii. Power      Normal                              Abnormal                 ..………… 
             iv. Muscle wasting:  Present              Absent            …………. 
4. REFLEXES:               Normal   Exaggerated  
        i. Knee jerk 
        ii. Ankle jerk 
 
 
20. CLINICAL ASSESSMENT: 
I. PAIN: 
A. Pain in the knee joints:      No                Mild       Moderate          Severe  
         i. Onset              Sudden                          Gradual              
         ii. Nature:           Local                             Diffuse          Others 
B. Nature of pain       Shooting                         Burning          Others     
       Yes                 No 
C. Pain during movements     
II. Morning stiffness 
III.Tenderness                                                                                                                                                                     
III. Swelling             
IV. Restricted joint movements                                                                                           
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FORM - VI PATIENT WITHDRAWAL FORM 
1.  OP / IP No       …………    2. S.No. ………………     3.Date: …………… 
4.  Name    ………………….. 5. Age ……………           6. Gender ………… 
7.  Postal address: 
------------------------------------------------------------------------------------------------ 
Complaints and Duration: 
 
Irregular treatment: 
 
Other causes: 
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FORM VII - DRUG COMPLIANCE FORM 
Name of the Drug: KARUNGOZHI  CHOORANAM  
Drugs issued: ……………(mgs/Grams) 
Drugs returned:  ……………(mgs/Grams) 
S.NO DATE 
DRUG TAKEN TIME 
MORNING/TI
ME 
AFTERNOON/T
IME 
NIGHT/TI
ME 
Day 1     
Day 2     
Day 3     
Day 4     
..     
 
 
 
Date:          
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                     Signature of the HOD 
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